GOBPID	Pvalue	OddsRatio	ExpCount	Count	Size	Term	IDs	adj
1	GO:0035107	2.71476743013226e-05	9.0371492704826	0.879924792752756	7	117	appendage morphogenesis	ASPH;BCL2L11;RDH10;SALL3;SOX4;TGFB2;WNT5A	0.0415766631924755
2	GO:0035108	2.71476743013226e-05	9.0371492704826	0.879924792752756	7	117	limb morphogenesis	ASPH;BCL2L11;RDH10;SALL3;SOX4;TGFB2;WNT5A	0.0415766631924755
3	GO:0042221	5.03931332778506e-05	2.4029551973915	23.5699512862149	41	3134	response to chemical	ACAA2;ANOS1;AQP4;ASPN;BCL2L11;CASP7;CYBRD1;EDEM3;FERMT2;FGF2;FIBIN;FKBP14;GNB4;GNG12;GSTO1;HAS2;IL33;ITGAV;KLHL15;LGALS3;LUM;MBD2;NAMPT;PAWR;PDGFRA;PIK3C2A;PLSCR4;PON2;PTN;PTPRZ1;RHOQ;RNF139;SLC30A1;SLC7A11;SOCS4;SOX4;SPRED1;SS18;TGFB2;TRA2B;WNT5A	0.0417278597459342
4	GO:1903292	5.59233376941265e-05	Inf	0.0150414494487651	2	2	protein localization to Golgi membrane	ARL5A;ARL5B	0.0417278597459342
5	GO:0048736	8.17391963681375e-05	7.5165544332211	1.04538073668917	7	139	appendage development	ASPH;BCL2L11;RDH10;SALL3;SOX4;TGFB2;WNT5A	0.0417278597459342
6	GO:0060173	8.17391963681375e-05	7.5165544332211	1.04538073668917	7	139	limb development	ASPH;BCL2L11;RDH10;SALL3;SOX4;TGFB2;WNT5A	0.0417278597459342
7	GO:0060412	0.00010346582781858	19.0213464696223	0.248183915904624	4	33	ventricular septum morphogenesis	RBM15;SOX4;TGFB2;WNT5A	0.0440651115602411
8	GO:0048514	0.000115090072635302	4.08662280701754	3.33920177762584	12	444	blood vessel morphogenesis	FGF2;HAS2;ITGAV;PDGFRA;PIK3C2A;PTN;RBM15;SOX4;SPRED1;TGFB2;TSPAN12;WNT5A	0.0440651115602411
9	GO:0001655	0.000137990352145191	5.17807594936709	1.94786770361508	9	259	urogenital system development	BCL2L11;FGF2;HAS2;ID4;PDGFRA;RDH10;SOX4;TGFB2;WNT5A	0.0464873798751024
10	GO:0009653	0.00015667626981307	2.45230373860368	14.8007862575848	29	1968	anatomical structure morphogenesis	ABI1;ANOS1;ASPH;ASPN;BCL2L11;CSNK1A1;FERMT2;FGF2;HAS2;ID4;ITGAV;KBTBD8;LUM;PDGFRA;PIK3C2A;PTBP3;PTN;PTPRZ1;RBM15;RDH10;RHOQ;RND3;SALL3;SOX4;SPRED1;SS18;TGFB2;TSPAN12;WNT5A	0.0464873798751024
11	GO:0048818	0.000166947821947805	270.046511627907	0.0225621741731476	2	3	positive regulation of hair follicle maturation	TGFB2;WNT5A	0.0464873798751024
12	GO:0035239	0.000214570810945436	3.41253876827647	4.6929322280147	14	624	tube morphogenesis	BCL2L11;FGF2;HAS2;ITGAV;PDGFRA;PIK3C2A;PTN;RBM15;RDH10;SOX4;SPRED1;TGFB2;TSPAN12;WNT5A	0.0547691994938224
13	GO:0010033	0.000251614303369094	2.30628174947342	17.5834544056064	32	2338	response to organic substance	ANOS1;AQP4;ASPN;BCL2L11;CASP7;EDEM3;FERMT2;FGF2;FIBIN;FKBP14;GNB4;GNG12;GSTO1;HAS2;IL33;KLHL15;LUM;MBD2;NAMPT;PDGFRA;PIK3C2A;PLSCR4;PTN;PTPRZ1;RHOQ;RNF139;SOCS4;SOX4;SPRED1;TGFB2;TRA2B;WNT5A	0.0566423411785679
14	GO:0042127	0.000280642194046727	2.72318644772397	8.66387488248868	20	1152	regulation of cell proliferation	ABI1;ASPH;BTG3;FGF2;HAS2;ID4;ITGAV;LGALS3;MARCH7;MBD2;NAMPT;PAWR;PDGFRA;PTN;PTPRZ1;RNF139;SOX4;SUZ12;TGFB2;WNT5A	0.0566423411785679
15	GO:0071310	0.000303194566165854	2.36923076923077	14.5826852405777	28	1939	cellular response to organic substance	ANOS1;AQP4;ASPN;BCL2L11;CASP7;EDEM3;FERMT2;FGF2;FKBP14;GNB4;GNG12;GSTO1;HAS2;IL33;KLHL15;MBD2;PDGFRA;PIK3C2A;PLSCR4;PTN;PTPRZ1;RHOQ;SOCS4;SOX4;SPRED1;TGFB2;TRA2B;WNT5A	0.0566423411785679
16	GO:0035905	0.000332260222933492	135.011627906977	0.0300828988975301	2	4	ascending aorta development	SOX4;TGFB2	0.0566423411785679
17	GO:0035910	0.000332260222933492	135.011627906977	0.0300828988975301	2	4	ascending aorta morphogenesis	SOX4;TGFB2	0.0566423411785679
18	GO:0072001	0.000347757946458105	5.084375	1.74480813605675	8	232	renal system development	BCL2L11;FGF2;HAS2;PDGFRA;RDH10;SOX4;TGFB2;WNT5A	0.0566423411785679
19	GO:0070887	0.000351356344235322	2.27445454331948	17.0870865737971	31	2272	cellular response to chemical stimulus	ACAA2;ANOS1;AQP4;ASPN;BCL2L11;CASP7;EDEM3;FERMT2;FGF2;FKBP14;GNB4;GNG12;GSTO1;HAS2;IL33;KLHL15;LGALS3;MBD2;PAWR;PDGFRA;PIK3C2A;PLSCR4;PTN;PTPRZ1;RHOQ;SOCS4;SOX4;SPRED1;TGFB2;TRA2B;WNT5A	0.0566423411785679
20	GO:0001568	0.0003715857203426	3.56899871630295	3.7904452610888	12	504	blood vessel development	FGF2;HAS2;ITGAV;PDGFRA;PIK3C2A;PTN;RBM15;SOX4;SPRED1;TGFB2;TSPAN12;WNT5A	0.0569083530704693
21	GO:0001944	0.00049224092206058	3.45161624533775	3.91077685667892	12	520	vasculature development	FGF2;HAS2;ITGAV;PDGFRA;PIK3C2A;PTN;RBM15;SOX4;SPRED1;TGFB2;TSPAN12;WNT5A	0.0649186576428523
22	GO:0007167	0.000503302341299238	2.99322413603144	5.72327151525511	15	761	enzyme linked receptor protein signaling pathway	ABI1;ANOS1;ASPN;FERMT2;FGF2;ITGAV;PDGFRA;PIK3C2A;PTN;RHOQ;SOCS4;SPRED1;SS18;TGFB2;WNT5A	0.0649186576428523
23	GO:0072358	0.000545320522886983	3.40948187589597	3.95590120502521	12	526	cardiovascular system development	FGF2;HAS2;ITGAV;PDGFRA;PIK3C2A;PTN;RBM15;SOX4;SPRED1;TGFB2;TSPAN12;WNT5A	0.0649186576428523
24	GO:0001525	0.000547946394602963	3.8957033957034	2.85787539526536	10	380	angiogenesis	FGF2;ITGAV;PDGFRA;PIK3C2A;PTN;RBM15;SPRED1;TGFB2;TSPAN12;WNT5A	0.0649186576428523
25	GO:0003289	0.000551056186325224	90	0.0376036236219127	2	5	atrial septum primum morphogenesis	SOX4;TGFB2	0.0649186576428523
26	GO:0021891	0.000551056186325224	90	0.0376036236219127	2	5	olfactory bulb interneuron development	SALL3;WNT5A	0.0649186576428523
27	GO:0042698	0.000709104018366776	11.012380952381	0.406119135116657	4	54	ovulation cycle	HAS2;PDGFRA;PTN;TGFB2	0.080443911416942
28	GO:0060411	0.000814194275124539	10.5869963369963	0.421160584565422	4	56	cardiac septum morphogenesis	RBM15;SOX4;TGFB2;WNT5A	0.0839813491367643
29	GO:0003284	0.000822540148254303	67.4941860465116	0.0451243483462952	2	6	septum primum development	SOX4;TGFB2	0.0839813491367643
30	GO:0072201	0.000822540148254303	67.4941860465116	0.0451243483462952	2	6	negative regulation of mesenchymal cell proliferation	PTN;WNT5A	0.0839813491367643
31	GO:0008406	0.0010164339752785	5.70731707317073	1.15067088283053	6	153	gonad development	BCL2L11;FNDC3A;PDGFRA;RDH10;TGFB2;WNT5A	0.0876509086601075
32	GO:0003281	0.00105657740923199	9.82738095238095	0.451243483462952	4	60	ventricular septum development	RBM15;SOX4;TGFB2;WNT5A	0.0876509086601075
33	GO:0044848	0.00114592525101973	53.9906976744186	0.0526450730706777	2	7	biological phase	TGFB2;WNT5A	0.0876509086601075
34	GO:0044851	0.00114592525101973	53.9906976744186	0.0526450730706777	2	7	hair cycle phase	TGFB2;WNT5A	0.0876509086601075
35	GO:0048819	0.00114592525101973	53.9906976744186	0.0526450730706777	2	7	regulation of hair follicle maturation	TGFB2;WNT5A	0.0876509086601075
36	GO:2000271	0.00114592525101973	53.9906976744186	0.0526450730706777	2	7	positive regulation of fibroblast apoptotic process	BCL2L11;STK17B	0.0876509086601075
37	GO:0045137	0.00116163597200086	5.55419156840575	1.18075378172806	6	157	development of primary sexual characteristics	BCL2L11;FNDC3A;PDGFRA;RDH10;TGFB2;WNT5A	0.0876509086601075
38	GO:0003209	0.00117536073562965	16.3595294117647	0.210580292282711	3	28	cardiac atrium morphogenesis	SOX4;TGFB2;WNT5A	0.0876509086601075
39	GO:0014009	0.00117536073562965	16.3595294117647	0.210580292282711	3	28	glial cell proliferation	IL33;PTN;SOX4	0.0876509086601075
40	GO:0048646	0.00118474275138195	2.7332309872461	6.21963934706435	15	827	anatomical structure formation involved in morphogenesis	ABI1;BCL2L11;FGF2;ITGAV;KBTBD8;PDGFRA;PIK3C2A;PTN;RBM15;RDH10;SOX4;SPRED1;TGFB2;TSPAN12;WNT5A	0.0876509086601075
41	GO:0010634	0.00119797880482187	6.8662769891447	0.797196820784548	5	106	positive regulation of epithelial cell migration	FGF2;HAS2;PIK3C2A;TGFB2;WNT5A	0.0876509086601075
42	GO:0007507	0.00120187338025613	3.49429159648138	3.16622510896505	10	421	heart development	FGF2;HAS2;MBD2;PDGFRA;PTN;RBM15;SOX4;SPRED1;TGFB2;WNT5A	0.0876509086601075
43	GO:0001822	0.00128535192514794	4.64750757046354	1.64703871463977	7	219	kidney development	BCL2L11;FGF2;HAS2;PDGFRA;RDH10;SOX4;TGFB2	0.0915589057378634
44	GO:0045765	0.00142669235366087	4.55984224965706	1.6771216135373	7	223	regulation of angiogenesis	FGF2;PIK3C2A;PTN;SPRED1;TGFB2;TSPAN12;WNT5A	0.0990869590211157
45	GO:0035295	0.00149853170013328	2.75987665517867	5.70823006580634	14	759	tube development	BCL2L11;FGF2;HAS2;ITGAV;PDGFRA;PIK3C2A;PTN;RBM15;RDH10;SOX4;SPRED1;TGFB2;TSPAN12;WNT5A	0.0990869590211157
46	GO:0010632	0.0014993593248689	5.2710538426139	1.24091957952312	6	165	regulation of epithelial cell migration	FGF2;HAS2;PIK3C2A;SPRED1;TGFB2;WNT5A	0.0990869590211157
47	GO:0021889	0.00152043325954699	44.9883720930233	0.0601657977950603	2	8	olfactory bulb interneuron differentiation	SALL3;WNT5A	0.0990869590211157
48	GO:0030334	0.00161445291087122	2.98188536409517	4.48235193573199	12	596	regulation of cell migration	FGF2;HAS2;IL33;ITGAV;LGALS3;PDGFRA;PIK3C2A;PTN;RND3;SPRED1;TGFB2;WNT5A	0.100889916545044
49	GO:0070848	0.00167876754838543	3.12933220625528	3.89573540723015	11	518	response to growth factor	ANOS1;ASPN;FERMT2;FGF2;HAS2;LUM;PDGFRA;PTN;SPRED1;TGFB2;WNT5A	0.100889916545044
50	GO:2000060	0.00168590965552518	8.59300595238095	0.511409281258012	4	68	positive regulation of ubiquitin-dependent protein catabolic process	CSNK1A1;IL33;RNF139;SOCS4	0.100889916545044
51	GO:0007166	0.00170516046139615	2.08004385964912	16.2146825057687	28	2156	cell surface receptor signaling pathway	ABI1;ANOS1;ASPN;BCL2L11;CSNK1A1;FERMT2;FGF2;GSTO1;IL33;ITGAV;LGALS3;MBD2;PAWR;PDGFRA;PIK3C2A;PTN;PTPRZ1;RBM15;RHOQ;SALL3;SCYL2;SOCS4;SOX4;SPRED1;SS18;TGFB2;TSPAN12;WNT5A	0.100889916545044
52	GO:0003230	0.00174137696431658	14.0981744421907	0.240663191180241	3	32	cardiac atrium development	SOX4;TGFB2;WNT5A	0.100889916545044
53	GO:0001501	0.00174572823274154	3.57131271816932	2.76762669857277	9	368	skeletal system development	ABI1;FGF2;HAS2;LUM;PDGFRA;RDH10;SOX4;TGFB2;WNT5A	0.100889916545044
54	GO:0032989	0.00183203693872404	2.60515997870178	6.49790616186651	15	864	cellular component morphogenesis	ABI1;ANOS1;CSNK1A1;FERMT2;HAS2;ITGAV;LUM;PDGFRA;PTN;PTPRZ1;RHOQ;RND3;SS18;TGFB2;WNT5A	0.102731672205485
55	GO:0070231	0.00190516807796638	13.6270588235294	0.248183915904624	3	33	T cell apoptotic process	BCL2L11;LGALS3;WNT5A	0.102731672205485
56	GO:0090049	0.00190516807796638	13.6270588235294	0.248183915904624	3	33	regulation of cell migration involved in sprouting angiogenesis	FGF2;PIK3C2A;SPRED1	0.102731672205485
57	GO:0042635	0.001945294478589	38.5581395348837	0.0676865225194428	2	9	positive regulation of hair cycle	TGFB2;WNT5A	0.102731672205485
58	GO:0051798	0.001945294478589	38.5581395348837	0.0676865225194428	2	9	positive regulation of hair follicle development	TGFB2;WNT5A	0.102731672205485
59	GO:0000902	0.0020079055290414	2.66783818929463	5.88872745919152	14	783	cell morphogenesis	ABI1;ANOS1;CSNK1A1;FERMT2;HAS2;ITGAV;LUM;PTN;PTPRZ1;RHOQ;RND3;SS18;TGFB2;WNT5A	0.104240926024641
60	GO:0007169	0.00216521453912013	3.023173391494	4.02358772754465	11	535	transmembrane receptor protein tyrosine kinase signaling pathway	ABI1;ANOS1;FGF2;ITGAV;PDGFRA;PIK3C2A;RHOQ;SOCS4;SPRED1;SS18;WNT5A	0.106235332889701
61	GO:1901342	0.00216829148735225	4.22084459280454	1.80497393385181	7	240	regulation of vasculature development	FGF2;PIK3C2A;PTN;SPRED1;TGFB2;TSPAN12;WNT5A	0.106235332889701
62	GO:0050896	0.00221246845707942	1.93264236582284	46.3727886505427	60	6166	response to stimulus	ABI1;ACAA2;ANOS1;AQP4;AQR;ASPN;BCL2L11;CASP7;CFI;CLEC2B;CSNK1A1;CYBRD1;DYRK3;EDEM3;FERMT2;FGF2;FGL2;FIBIN;FKBP14;GNB4;GNG12;GSTO1;HAS2;IL33;ITGAV;KLHL15;LGALS3;LPAR4;LUM;MAP3K2;MBD2;NAMPT;OSGIN2;PAWR;PDGFRA;PGM2;PIK3C2A;PLOD2;PLSCR4;PON2;PTN;PTPRZ1;RAB39A;RBM15;RHOQ;RND3;RNF139;SALL3;SCYL2;SLC30A1;SLC7A11;SOCS4;SOX4;SPRED1;SS18;STK17B;TGFB2;TRA2B;TSPAN12;WNT5A	0.106235332889701
63	GO:0008283	0.00221811547847383	2.22131334968611	10.9576959234253	21	1457	cell proliferation	ABI1;ASPH;BTG3;FGF2;HAS2;ID4;IL33;ITGAV;LGALS3;MARCH7;MBD2;NAMPT;PAWR;PDGFRA;PTN;PTPRZ1;RNF139;SOX4;SUZ12;TGFB2;WNT5A	0.106235332889701
64	GO:0045862	0.00221973924418572	4.20243748021526	1.81249465857619	7	241	positive regulation of proteolysis	ASPH;BCL2L11;CASP7;CSNK1A1;IL33;RNF139;SOCS4	0.106235332889701
65	GO:0043010	0.00237977255413113	4.14814814814815	1.83505683274934	7	244	camera-type eye development	PDGFRA;PTN;RDH10;SLC7A11;TGFB2;TSPAN12;WNT5A	0.112142205127748
66	GO:2000145	0.00270318221300659	2.7900660010154	4.76813947525852	12	634	regulation of cell motility	FGF2;HAS2;IL33;ITGAV;LGALS3;PDGFRA;PIK3C2A;PTN;RND3;SPRED1;TGFB2;WNT5A	0.118742164076204
67	GO:0048608	0.0027607123250709	3.62211538461538	2.40663191180241	8	320	reproductive structure development	BCL2L11;FNDC3A;ID4;PDGFRA;RBM15;RDH10;TGFB2;WNT5A	0.118742164076204
68	GO:0061458	0.00286838733912676	3.5984076433121	2.42167336125117	8	322	reproductive system development	BCL2L11;FNDC3A;ID4;PDGFRA;RBM15;RDH10;TGFB2;WNT5A	0.118742164076204
69	GO:0008360	0.00294007915420813	5.53638554216867	0.977694214169729	5	130	regulation of cell shape	CSNK1A1;FERMT2;PTN;RHOQ;RND3	0.118742164076204
70	GO:0010934	0.00294303997471591	29.984496124031	0.0827279719682078	2	11	macrophage cytokine production	TGFB2;WNT5A	0.118742164076204
71	GO:0010935	0.00294303997471591	29.984496124031	0.0827279719682078	2	11	regulation of macrophage cytokine production	TGFB2;WNT5A	0.118742164076204
72	GO:0008543	0.00305809822436541	7.22869674185464	0.601657977950602	4	80	fibroblast growth factor receptor signaling pathway	ANOS1;FGF2;SPRED1;WNT5A	0.118742164076204
73	GO:0055082	0.00308434872955571	2.87900078064012	4.21160584565422	11	560	cellular chemical homeostasis	CYBRD1;FGF2;GSTO1;ITGAV;LPAR4;PDGFRA;RAB39A;SLC30A1;SLC4A7;SOX4;TRA2B	0.118742164076204
74	GO:1903052	0.00319873741132253	7.13419913419913	0.609178702674985	4	81	positive regulation of proteolysis involved in cellular protein catabolic process	CSNK1A1;IL33;RNF139;SOCS4	0.118742164076204
75	GO:0009790	0.00322606328257912	2.61464450600185	5.52773267242116	13	735	embryo development	ABI1;BCL2L11;FGF2;ITGAV;KBTBD8;MBD2;PDGFRA;RDH10;SLC30A1;SOX4;TGFB2;TRA2B;WNT5A	0.118742164076204
76	GO:0042063	0.00329424197434395	4.47084909351767	1.45149987180583	6	193	gliogenesis	ID4;IL33;PTN;PTPRZ1;SOX4;TGFB2	0.118742164076204
77	GO:0002042	0.00332178519029875	11.0422893481717	0.300828988975301	3	40	cell migration involved in sprouting angiogenesis	FGF2;PIK3C2A;SPRED1	0.118742164076204
78	GO:0050918	0.00332178519029875	11.0422893481717	0.300828988975301	3	40	positive chemotaxis	FGF2;LGALS3;WNT5A	0.118742164076204
79	GO:2000269	0.00351442682551621	26.9837209302326	0.0902486966925904	2	12	regulation of fibroblast apoptotic process	BCL2L11;STK17B	0.118742164076204
80	GO:0050793	0.00357107368594692	2.03767313019391	13.7554055208956	24	1829	regulation of developmental process	ASPN;BCL2L11;CSNK1A1;FERMT2;FGF2;HAS2;ID4;ITGAV;LGALS3;MARCH7;PAWR;PDGFRA;PIK3C2A;PTBP3;PTN;PTPRZ1;RBM15;RHOQ;RND3;SPRED1;SUZ12;TGFB2;TSPAN12;WNT5A	0.118742164076204
81	GO:0048585	0.00362163027047165	2.23759398496241	9.13768054012478	18	1215	negative regulation of response to stimulus	ACAA2;ASPN;CSNK1A1;DYRK3;FGF2;GSTO1;IL33;ITGAV;KLHL15;LGALS3;PAWR;PDGFRA;SALL3;SCYL2;SOCS4;SPRED1;TGFB2;WNT5A	0.118742164076204
82	GO:0007548	0.00364396177175876	4.37568637466479	1.48158277070336	6	197	sex differentiation	BCL2L11;FNDC3A;PDGFRA;RDH10;TGFB2;WNT5A	0.118742164076204
83	GO:0010648	0.0037120051328274	2.33796296296296	7.70122211776771	16	1024	negative regulation of cell communication	ACAA2;ASPN;CSNK1A1;DYRK3;GSTO1;ITGAV;LGALS3;PAWR;PDGFRA;SALL3;SCYL2;SLC30A1;SOCS4;SPRED1;TGFB2;WNT5A	0.118742164076204
84	GO:0023057	0.00382044164812325	2.33036597428289	7.72378429194086	16	1027	negative regulation of signaling	ACAA2;ASPN;CSNK1A1;DYRK3;GSTO1;ITGAV;LGALS3;PAWR;PDGFRA;SALL3;SCYL2;SLC30A1;SOCS4;SPRED1;TGFB2;WNT5A	0.118742164076204
85	GO:0071363	0.00397844131199462	2.93526432415321	3.73027946329374	10	496	cellular response to growth factor stimulus	ANOS1;ASPN;FERMT2;FGF2;HAS2;PDGFRA;PTN;SPRED1;TGFB2;WNT5A	0.118742164076204
86	GO:0098657	0.00408040370846284	2.76766917293233	4.36954106486625	11	581	import into cell	ABI1;CFI;CSNK1A1;ITGAV;LGALS3;PIK3C2A;RAB39A;RHOQ;SCYL2;SLC30A1;WNT5A	0.118742164076204
87	GO:0060413	0.00413317187375916	24.5285412262156	0.0977694214169729	2	13	atrial septum morphogenesis	SOX4;TGFB2	0.118742164076204
88	GO:0070242	0.00413317187375916	24.5285412262156	0.0977694214169729	2	13	thymocyte apoptotic process	BCL2L11;WNT5A	0.118742164076204
89	GO:0003279	0.00413623818550671	6.61503155479059	0.65430305102128	4	87	cardiac septum development	RBM15;SOX4;TGFB2;WNT5A	0.118742164076204
90	GO:0010631	0.00421944134411483	4.24018818868392	1.52670711904965	6	203	epithelial cell migration	FGF2;HAS2;PIK3C2A;SPRED1;TGFB2;WNT5A	0.118742164076204
91	GO:0008285	0.00426964786674062	2.90406809755079	3.76788308691565	10	501	negative regulation of cell proliferation	ABI1;ASPH;BTG3;MARCH7;PAWR;PTN;RNF139;SOX4;TGFB2;WNT5A	0.118742164076204
92	GO:0007423	0.00429491498228981	3.09724099791078	3.16622510896505	9	421	sensory organ development	BCL2L11;PDGFRA;PTN;RDH10;SLC4A7;SLC7A11;TGFB2;TSPAN12;WNT5A	0.118742164076204
93	GO:0009887	0.00438588305301692	2.51414330218069	5.73079223997949	13	762	animal organ morphogenesis	ASPN;BCL2L11;FGF2;HAS2;ID4;PDGFRA;PTN;RBM15;RDH10;SOX4;TGFB2;TSPAN12;WNT5A	0.118742164076204
94	GO:0090132	0.00442545746520458	4.19683784777546	1.54174856849842	6	205	epithelium migration	FGF2;HAS2;PIK3C2A;SPRED1;TGFB2;WNT5A	0.118742164076204
95	GO:0009968	0.00458625689833692	2.34391464699684	7.15220921288779	15	951	negative regulation of signal transduction	ACAA2;ASPN;CSNK1A1;DYRK3;GSTO1;ITGAV;LGALS3;PAWR;PDGFRA;SALL3;SCYL2;SOCS4;SPRED1;TGFB2;WNT5A	0.118742164076204
96	GO:0030335	0.00466930078471489	3.30557184750733	2.6247329288095	8	349	positive regulation of cell migration	FGF2;HAS2;ITGAV;LGALS3;PDGFRA;PIK3C2A;TGFB2;WNT5A	0.118742164076204
97	GO:0090130	0.00474831643663563	4.13342187877324	1.56431074267157	6	208	tissue migration	FGF2;HAS2;PIK3C2A;SPRED1;TGFB2;WNT5A	0.118742164076204
98	GO:0043009	0.00478079321923786	3.04359384912843	3.21887018203572	9	428	chordate embryonic development	ABI1;BCL2L11;KBTBD8;PDGFRA;RDH10;SLC30A1;SOX4;TGFB2;WNT5A	0.118742164076204
99	GO:0006474	0.00479854690688638	22.4825581395349	0.105290146141355	2	14	N-terminal protein amino acid acetylation	NAA50;SOX4	0.118742164076204
100	GO:0044849	0.00479854690688638	22.4825581395349	0.105290146141355	2	14	estrous cycle	HAS2;PTN	0.118742164076204
101	GO:0048820	0.00479854690688638	22.4825581395349	0.105290146141355	2	14	hair follicle maturation	TGFB2;WNT5A	0.118742164076204
102	GO:0050860	0.00479854690688638	22.4825581395349	0.105290146141355	2	14	negative regulation of T cell receptor signaling pathway	LGALS3;PAWR	0.118742164076204
103	GO:0060602	0.00479854690688638	22.4825581395349	0.105290146141355	2	14	branch elongation of an epithelium	RDH10;WNT5A	0.118742164076204
104	GO:0010469	0.0049135447012018	3.27587209302326	2.64729510298265	8	352	regulation of signaling receptor activity	FGF2;IL33;NAMPT;OSGIN2;PTN;SOCS4;TGFB2;WNT5A	0.118742164076204
105	GO:0045732	0.00511035049656521	4.83191507287893	1.11306725920861	5	148	positive regulation of protein catabolic process	CSNK1A1;IL33;RNF139;SOCS4;WNT5A	0.118742164076204
106	GO:0001654	0.00517676709058198	3.57632693520771	2.11332364755149	7	281	eye development	PDGFRA;PTN;RDH10;SLC7A11;TGFB2;TSPAN12;WNT5A	0.118742164076204
107	GO:0018193	0.00524902468915882	2.30634462869503	7.25749935902914	15	965	peptidyl-amino acid modification	ABI1;ASPH;CSNK1A1;DPY19L3;DYRK3;FGF2;FKBP14;NAA50;PDGFRA;PLOD2;SOCS4;SOX4;SPRED1;SUZ12;WNT5A	0.118742164076204
108	GO:2000147	0.00543145184722033	3.218	2.69241945132895	8	358	positive regulation of cell motility	FGF2;HAS2;ITGAV;LGALS3;PDGFRA;PIK3C2A;TGFB2;WNT5A	0.118742164076204
109	GO:0048511	0.00544576113465872	4.01207786116323	1.60943509101786	6	214	rhythmic process	HAS2;ID4;NAMPT;PDGFRA;PTN;TGFB2	0.118742164076204
110	GO:0022612	0.00544621848915737	6.0968253968254	0.706948124091958	4	94	gland morphogenesis	ID4;PTN;TGFB2;WNT5A	0.118742164076204
111	GO:1903364	0.00544621848915737	6.0968253968254	0.706948124091958	4	94	positive regulation of cellular protein catabolic process	CSNK1A1;IL33;RNF139;SOCS4	0.118742164076204
112	GO:0003215	0.00550983177060954	20.7513416815742	0.112810870865738	2	15	cardiac right ventricle morphogenesis	SOX4;TGFB2	0.118742164076204
113	GO:0044346	0.00550983177060954	20.7513416815742	0.112810870865738	2	15	fibroblast apoptotic process	BCL2L11;STK17B	0.118742164076204
114	GO:0060065	0.00550983177060954	20.7513416815742	0.112810870865738	2	15	uterus development	TGFB2;WNT5A	0.118742164076204
115	GO:0060572	0.00550983177060954	20.7513416815742	0.112810870865738	2	15	morphogenesis of an epithelial bud	RDH10;WNT5A	0.118742164076204
116	GO:0072359	0.00556373513113476	2.43745784695201	5.8962481839159	13	784	circulatory system development	FGF2;HAS2;ITGAV;MBD2;PDGFRA;PIK3C2A;PTN;RBM15;SOX4;SPRED1;TGFB2;TSPAN12;WNT5A	0.118742164076204
117	GO:0070227	0.00556944715426718	9.07294117647059	0.360994786770362	3	48	lymphocyte apoptotic process	BCL2L11;LGALS3;WNT5A	0.118742164076204
118	GO:0051270	0.00558755779437737	2.53071461645316	5.21938295872148	12	694	regulation of cellular component movement	FGF2;HAS2;IL33;ITGAV;LGALS3;PDGFRA;PIK3C2A;PTN;RND3;SPRED1;TGFB2;WNT5A	0.118742164076204
119	GO:0006897	0.00560786232445727	2.78538812785388	3.9182975814033	10	521	endocytosis	ABI1;CFI;CSNK1A1;ITGAV;LGALS3;PIK3C2A;RAB39A;RHOQ;SCYL2;WNT5A	0.118742164076204
120	GO:0040012	0.00565094782536742	2.52677814595053	5.22690368344586	12	695	regulation of locomotion	FGF2;HAS2;IL33;ITGAV;LGALS3;PDGFRA;PIK3C2A;PTN;RND3;SPRED1;TGFB2;WNT5A	0.118742164076204
121	GO:1903510	0.00565349790760729	6.02930402930403	0.71446884881634	4	95	mucopolysaccharide metabolic process	CSGALNACT2;FGF2;HAS2;LUM	0.118742164076204
122	GO:0051247	0.00587069460447733	2.16798975672215	8.81428937697633	17	1172	positive regulation of protein metabolic process	ABI1;ASPH;BCL2L11;CASP7;CSNK1A1;FBXO5;FGF2;IL33;ITGAV;MAP3K2;PAWR;PDGFRA;RNF139;SOCS4;SOX4;TGFB2;WNT5A	0.118742164076204
123	GO:0009792	0.00588082487709716	2.94150320109919	3.32416032817708	9	442	embryo development ending in birth or egg hatching	ABI1;BCL2L11;KBTBD8;PDGFRA;RDH10;SLC30A1;SOX4;TGFB2;WNT5A	0.118742164076204
124	GO:0003407	0.0059007911668396	8.87493606138107	0.368515511494744	3	49	neural retina development	PTN;TGFB2;TSPAN12	0.118742164076204
125	GO:0051272	0.00618596552412011	3.14385474860335	2.75258524912401	8	366	positive regulation of cellular component movement	FGF2;HAS2;ITGAV;LGALS3;PDGFRA;PIK3C2A;TGFB2;WNT5A	0.118742164076204
126	GO:0033692	0.00624371495214141	8.68535669586984	0.376036236219127	3	50	cellular polysaccharide biosynthetic process	CSGALNACT2;HAS2;PGM2	0.118742164076204
127	GO:0036507	0.00626631429113368	19.2674418604651	0.120331595590121	2	16	protein demannosylation	EDEM3;RNF139	0.118742164076204
128	GO:0036508	0.00626631429113368	19.2674418604651	0.120331595590121	2	16	protein alpha-1,2-demannosylation	EDEM3;RNF139	0.118742164076204
129	GO:0051797	0.00626631429113368	19.2674418604651	0.120331595590121	2	16	regulation of hair follicle development	TGFB2;WNT5A	0.118742164076204
130	GO:0061082	0.00626631429113368	19.2674418604651	0.120331595590121	2	16	myeloid leukocyte cytokine production	TGFB2;WNT5A	0.118742164076204
131	GO:0008584	0.00630682280309905	5.83535967578521	0.737031022989488	4	98	male gonad development	BCL2L11;FNDC3A;TGFB2;WNT5A	0.118742164076204
132	GO:0009719	0.00644003796959774	2.14527818713309	8.89701734894454	17	1183	response to endogenous stimulus	ANOS1;ASPN;BCL2L11;CASP7;FERMT2;FGF2;FIBIN;GNB4;GNG12;HAS2;MBD2;PIK3C2A;PTN;RHOQ;SPRED1;TGFB2;WNT5A	0.118742164076204
133	GO:0048513	0.0064677397855647	1.84498081686174	18.5912315186736	29	2472	animal organ development	ABI1;ASPN;BCL2L11;DYRK3;FGF2;FNDC3A;GNB4;GNG12;HAS2;ID4;KBTBD8;LGALS3;LUM;MBD2;PDGFRA;PTBP3;PTN;PTPRZ1;RBM15;RDH10;SALL3;SLC4A7;SLC7A11;SOX4;SPRED1;TGFB2;TRA2B;TSPAN12;WNT5A	0.118742164076204
134	GO:0030326	0.00653528070103612	5.7734335839599	0.744551747713871	4	99	embryonic limb morphogenesis	BCL2L11;RDH10;TGFB2;WNT5A	0.118742164076204
135	GO:0035113	0.00653528070103612	5.7734335839599	0.744551747713871	4	99	embryonic appendage morphogenesis	BCL2L11;RDH10;TGFB2;WNT5A	0.118742164076204
136	GO:0046546	0.00653528070103612	5.7734335839599	0.744551747713871	4	99	development of primary male sexual characteristics	BCL2L11;FNDC3A;TGFB2;WNT5A	0.118742164076204
137	GO:0048762	0.00653991844251281	4.54224793912492	1.18075378172806	5	157	mesenchymal cell differentiation	HAS2;KBTBD8;RDH10;TGFB2;WNT5A	0.118742164076204
138	GO:0007155	0.00656633475506312	2.24445163286546	7.43799675241432	15	989	cell adhesion	ANOS1;BCL2L11;FERMT2;FNDC3A;HAS2;ITGAV;LGALS3;MARCH7;PAWR;PDGFRA;PTN;RND3;SLC7A11;TGFB2;WNT5A	0.118742164076204
139	GO:1904888	0.00659832118236494	8.50367647058824	0.383556960943509	3	51	cranial skeletal system development	PDGFRA;RDH10;TGFB2	0.118742164076204
140	GO:0022610	0.00687196703423695	2.23193921670141	7.47560037603624	15	994	biological adhesion	ANOS1;BCL2L11;FERMT2;FNDC3A;HAS2;ITGAV;LGALS3;MARCH7;PAWR;PDGFRA;PTN;RND3;SLC7A11;TGFB2;WNT5A	0.118742164076204
141	GO:0030003	0.00687540348145904	2.86580567909682	3.40688830014529	9	453	cellular cation homeostasis	CYBRD1;FGF2;GSTO1;ITGAV;LPAR4;PDGFRA;RAB39A;SLC30A1;SLC4A7	0.118742164076204
142	GO:1903670	0.00696470827823826	8.32941176470588	0.391077685667892	3	52	regulation of sprouting angiogenesis	FGF2;PIK3C2A;SPRED1	0.118742164076204
143	GO:0071495	0.00699740338801501	2.2269699635541	7.490641825485	15	996	cellular response to endogenous stimulus	ANOS1;ASPN;BCL2L11;CASP7;FERMT2;FGF2;GNB4;GNG12;HAS2;PIK3C2A;PTN;RHOQ;SPRED1;TGFB2;WNT5A	0.118742164076204
144	GO:0003206	0.00700855143391667	5.653411880216	0.759593197162636	4	101	cardiac chamber morphogenesis	RBM15;SOX4;TGFB2;WNT5A	0.118742164076204
145	GO:0022603	0.00705548812042458	2.36183039462636	6.0692248525767	13	807	regulation of anatomical structure morphogenesis	ASPN;CSNK1A1;FERMT2;FGF2;HAS2;PIK3C2A;PTN;RHOQ;RND3;SPRED1;TGFB2;TSPAN12;WNT5A	0.118742164076204
146	GO:0003283	0.00706729019807393	17.9813953488372	0.127852320314503	2	17	atrial septum development	SOX4;TGFB2	0.118742164076204
147	GO:0006833	0.00706729019807393	17.9813953488372	0.127852320314503	2	17	water transport	AQP4;HAS2	0.118742164076204
148	GO:0043032	0.00706729019807393	17.9813953488372	0.127852320314503	2	17	positive regulation of macrophage activation	IL33;WNT5A	0.118742164076204
149	GO:0090050	0.00706729019807393	17.9813953488372	0.127852320314503	2	17	positive regulation of cell migration involved in sprouting angiogenesis	FGF2;PIK3C2A	0.118742164076204
150	GO:2000058	0.00725347215080756	5.59523809523809	0.767113921887018	4	102	regulation of ubiquitin-dependent protein catabolic process	CSNK1A1;IL33;RNF139;SOCS4	0.118742164076204
151	GO:0009888	0.0074742447999905	2.03184014053579	10.5666182377575	19	1405	tissue development	ABI1;ASPN;FGF2;FNDC3A;HAS2;ID4;ITGAV;KBTBD8;LGALS3;LUM;PDGFRA;PTN;RBM15;RDH10;SLC4A7;SLC7A11;SOX4;TGFB2;WNT5A	0.118742164076204
152	GO:0014810	0.00752072472438248	Inf	0.00752072472438253	1	1	positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion	GSTO1	0.118742164076204
153	GO:0014843	0.00752072472438248	Inf	0.00752072472438253	1	1	growth factor dependent regulation of skeletal muscle satellite cell proliferation	FGF2	0.118742164076204
154	GO:0036517	0.00752072472438248	Inf	0.00752072472438253	1	1	chemoattraction of serotonergic neuron axon	WNT5A	0.118742164076204
155	GO:0042660	0.00752072472438248	Inf	0.00752072472438253	1	1	positive regulation of cell fate specification	FGF2	0.118742164076204
156	GO:0045726	0.00752072472438248	Inf	0.00752072472438253	1	1	positive regulation of integrin biosynthetic process	TGFB2	0.118742164076204
157	GO:0050652	0.00752072472438248	Inf	0.00752072472438253	1	1	dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process	CSGALNACT2	0.118742164076204
158	GO:0051025	0.00752072472438248	Inf	0.00752072472438253	1	1	negative regulation of immunoglobulin secretion	IL33	0.118742164076204
159	GO:0051885	0.00752072472438248	Inf	0.00752072472438253	1	1	positive regulation of timing of anagen	WNT5A	0.118742164076204
160	GO:0052066	0.00752072472438248	Inf	0.00752072472438253	1	1	entry of symbiont into host cell by promotion of host phagocytosis	ITGAV	0.118742164076204
161	GO:0052190	0.00752072472438248	Inf	0.00752072472438253	1	1	modulation by symbiont of host phagocytosis	ITGAV	0.118742164076204
162	GO:0052191	0.00752072472438248	Inf	0.00752072472438253	1	1	positive regulation by symbiont of host phagocytosis	ITGAV	0.118742164076204
163	GO:0052231	0.00752072472438248	Inf	0.00752072472438253	1	1	modulation of phagocytosis in other organism involved in symbiotic interaction	ITGAV	0.118742164076204
164	GO:0052370	0.00752072472438248	Inf	0.00752072472438253	1	1	entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction	ITGAV	0.118742164076204
165	GO:0052522	0.00752072472438248	Inf	0.00752072472438253	1	1	positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction	ITGAV	0.118742164076204
166	GO:0060599	0.00752072472438248	Inf	0.00752072472438253	1	1	lateral sprouting involved in mammary gland duct morphogenesis	WNT5A	0.118742164076204
167	GO:0060809	0.00752072472438248	Inf	0.00752072472438253	1	1	mesodermal to mesenchymal transition involved in gastrulation	WNT5A	0.118742164076204
168	GO:0061347	0.00752072472438248	Inf	0.00752072472438253	1	1	planar cell polarity pathway involved in outflow tract morphogenesis	WNT5A	0.118742164076204
169	GO:0061348	0.00752072472438248	Inf	0.00752072472438253	1	1	planar cell polarity pathway involved in ventricular septum morphogenesis	WNT5A	0.118742164076204
170	GO:0061349	0.00752072472438248	Inf	0.00752072472438253	1	1	planar cell polarity pathway involved in cardiac right atrium morphogenesis	WNT5A	0.118742164076204
171	GO:0061350	0.00752072472438248	Inf	0.00752072472438253	1	1	planar cell polarity pathway involved in cardiac muscle tissue morphogenesis	WNT5A	0.118742164076204
172	GO:0061354	0.00752072472438248	Inf	0.00752072472438253	1	1	planar cell polarity pathway involved in pericardium morphogenesis	WNT5A	0.118742164076204
173	GO:0061642	0.00752072472438248	Inf	0.00752072472438253	1	1	chemoattraction of axon	WNT5A	0.118742164076204
174	GO:0061682	0.00752072472438248	Inf	0.00752072472438253	1	1	seminal vesicle morphogenesis	ID4	0.118742164076204
175	GO:0070171	0.00752072472438248	Inf	0.00752072472438253	1	1	negative regulation of tooth mineralization	ASPN	0.118742164076204
176	GO:0071579	0.00752072472438248	Inf	0.00752072472438253	1	1	regulation of zinc ion transport	SLC30A1	0.118742164076204
177	GO:0071580	0.00752072472438248	Inf	0.00752072472438253	1	1	regulation of zinc ion transmembrane transport	SLC30A1	0.118742164076204
178	GO:0071581	0.00752072472438248	Inf	0.00752072472438253	1	1	regulation of zinc ion transmembrane import	SLC30A1	0.118742164076204
179	GO:0071582	0.00752072472438248	Inf	0.00752072472438253	1	1	negative regulation of zinc ion transport	SLC30A1	0.118742164076204
180	GO:0071583	0.00752072472438248	Inf	0.00752072472438253	1	1	negative regulation of zinc ion transmembrane transport	SLC30A1	0.118742164076204
181	GO:0071584	0.00752072472438248	Inf	0.00752072472438253	1	1	negative regulation of zinc ion transmembrane import	SLC30A1	0.118742164076204
182	GO:0071585	0.00752072472438248	Inf	0.00752072472438253	1	1	detoxification of cadmium ion	SLC30A1	0.118742164076204
183	GO:1903701	0.00752072472438248	Inf	0.00752072472438253	1	1	substantia propria of cornea development	TGFB2	0.118742164076204
184	GO:1904373	0.00752072472438248	Inf	0.00752072472438253	1	1	response to kainic acid	PTN	0.118742164076204
185	GO:1904389	0.00752072472438248	Inf	0.00752072472438253	1	1	rod bipolar cell differentiation	PTN	0.118742164076204
186	GO:1904391	0.00752072472438248	Inf	0.00752072472438253	1	1	response to ciliary neurotrophic factor	PTN	0.118742164076204
187	GO:1904933	0.00752072472438248	Inf	0.00752072472438253	1	1	regulation of cell proliferation in midbrain	WNT5A	0.118742164076204
188	GO:1904934	0.00752072472438248	Inf	0.00752072472438253	1	1	negative regulation of cell proliferation in midbrain	WNT5A	0.118742164076204
189	GO:1904955	0.00752072472438248	Inf	0.00752072472438253	1	1	planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation	WNT5A	0.118742164076204
190	GO:1905438	0.00752072472438248	Inf	0.00752072472438253	1	1	non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	WNT5A	0.118742164076204
191	GO:1990170	0.00752072472438248	Inf	0.00752072472438253	1	1	stress response to cadmium ion	SLC30A1	0.118742164076204
192	GO:2000536	0.00752072472438248	Inf	0.00752072472438253	1	1	negative regulation of entry of bacterium into host cell	ITGAV	0.118742164076204
193	GO:2000759	0.00752072472438248	Inf	0.00752072472438253	1	1	regulation of N-terminal peptidyl-lysine acetylation	SOX4	0.118742164076204
194	GO:2000761	0.00752072472438248	Inf	0.00752072472438253	1	1	positive regulation of N-terminal peptidyl-lysine acetylation	SOX4	0.118742164076204
195	GO:0051051	0.00773069201013526	3.3040957624291	2.27877959148791	7	303	negative regulation of transport	ACAA2;GSTO1;IL33;ITGAV;LGALS3;SLC30A1;SOX4	0.12022029657974
196	GO:0044344	0.00776014896646171	5.48238095238095	0.782155371335783	4	104	cellular response to fibroblast growth factor stimulus	ANOS1;FGF2;SPRED1;WNT5A	0.12022029657974
197	GO:0008284	0.00776558002877238	2.52006420545746	4.76813947525852	11	634	positive regulation of cell proliferation	FGF2;HAS2;ID4;ITGAV;NAMPT;PDGFRA;PTN;SOX4;SUZ12;TGFB2;WNT5A	0.12022029657974
198	GO:0032270	0.00777134140476282	2.1453618756371	8.31792154516708	16	1106	positive regulation of cellular protein metabolic process	ABI1;ASPH;BCL2L11;CASP7;CSNK1A1;FBXO5;FGF2;IL33;ITGAV;MAP3K2;PDGFRA;RNF139;SOCS4;SOX4;TGFB2;WNT5A	0.12022029657974
199	GO:0033119	0.00791206304805991	16.8561046511628	0.135373045038886	2	18	negative regulation of RNA splicing	PTBP3;TRA2B	0.120570393612973
200	GO:0036120	0.00791206304805991	16.8561046511628	0.135373045038886	2	18	cellular response to platelet-derived growth factor stimulus	HAS2;PTN	0.120570393612973
201	GO:0050858	0.00791206304805991	16.8561046511628	0.135373045038886	2	18	negative regulation of antigen receptor-mediated signaling pathway	LGALS3;PAWR	0.120570393612973
202	GO:0006873	0.00799503658078152	2.7937682570594	3.48961627211349	9	464	cellular ion homeostasis	CYBRD1;FGF2;GSTO1;ITGAV;LPAR4;PDGFRA;RAB39A;SLC30A1;SLC4A7	0.120577748662929
203	GO:0003231	0.00802200889885665	5.42762847713343	0.789676096060166	4	105	cardiac ventricle development	RBM15;SOX4;TGFB2;WNT5A	0.120577748662929
204	GO:0048878	0.00803064339772688	2.32099132589839	6.16699427399368	13	820	chemical homeostasis	AQP4;CYBRD1;FGF2;GSTO1;HAS2;ITGAV;LPAR4;PDGFRA;RAB39A;SLC30A1;SLC4A7;SOX4;TRA2B	0.120577748662929
205	GO:0040017	0.00817451580789574	2.98856382978723	2.88795829416289	8	384	positive regulation of locomotion	FGF2;HAS2;ITGAV;LGALS3;PDGFRA;PIK3C2A;TGFB2;WNT5A	0.122139228876023
206	GO:0001837	0.00828961792215214	5.37394957983193	0.797196820784548	4	106	epithelial to mesenchymal transition	HAS2;KBTBD8;TGFB2;WNT5A	0.123257765512388
207	GO:0060322	0.00861828399270236	2.60362267701717	4.17400222203231	10	555	head development	ASPH;BCL2L11;GNB4;GNG12;ID4;PTN;SALL3;SLC7A11;TRA2B;WNT5A	0.126912518604074
208	GO:0098609	0.00861828399270236	2.60362267701717	4.17400222203231	10	555	cell-cell adhesion	FNDC3A;HAS2;ITGAV;LGALS3;MARCH7;PAWR;PDGFRA;SLC7A11;TGFB2;WNT5A	0.126912518604074
209	GO:0018126	0.00879994414902197	15.8632010943912	0.142893769763268	2	19	protein hydroxylation	ASPH;PLOD2	0.127745160798362
210	GO:0036119	0.00879994414902197	15.8632010943912	0.142893769763268	2	19	response to platelet-derived growth factor	HAS2;PTN	0.127745160798362
211	GO:1905809	0.00879994414902197	15.8632010943912	0.142893769763268	2	19	negative regulation of synapse organization	PTN;WNT5A	0.127745160798362
212	GO:0032436	0.00897651276938667	7.55490196078431	0.428681309289804	3	57	positive regulation of proteasomal ubiquitin-dependent protein catabolic process	CSNK1A1;IL33;SOCS4	0.129693672701091
213	GO:0071774	0.00912743787438125	5.21904761904762	0.819758994957696	4	109	response to fibroblast growth factor	ANOS1;FGF2;SPRED1;WNT5A	0.131255127742863
214	GO:0000271	0.00941542267889501	7.41689839572193	0.436202034014187	3	58	polysaccharide biosynthetic process	CSGALNACT2;HAS2;PGM2	0.133649163058407
215	GO:0048468	0.00950910157589163	1.94855355142714	11.6044782497222	20	1543	cell development	ABI1;ANOS1;FBXO5;FERMT2;FNDC3A;HAS2;ID4;ITGAV;KBTBD8;LUM;PDGFRA;PTBP3;PTN;PTPRZ1;RDH10;SALL3;SLC4A7;SOX4;TGFB2;WNT5A	0.133649163058407
216	GO:0043583	0.00951186085341013	4.1288507322704	1.2935646525938	5	172	ear development	BCL2L11;RDH10;SLC4A7;TGFB2;WNT5A	0.133649163058407
217	GO:0097191	0.00951186085341013	4.1288507322704	1.2935646525938	5	172	extrinsic apoptotic signaling pathway	BCL2L11;IL33;ITGAV;LGALS3;TGFB2	0.133649163058407
218	GO:0003181	0.00973025248515336	14.9806201550388	0.150414494487651	2	20	atrioventricular valve morphogenesis	SOX4;TGFB2	0.133649163058407
219	GO:0021884	0.00973025248515336	14.9806201550388	0.150414494487651	2	20	forebrain neuron development	SALL3;WNT5A	0.133649163058407
220	GO:0034067	0.00973025248515336	14.9806201550388	0.150414494487651	2	20	protein localization to Golgi apparatus	ARL5A;ARL5B	0.133649163058407
221	GO:0060561	0.00973025248515336	14.9806201550388	0.150414494487651	2	20	apoptotic process involved in morphogenesis	BCL2L11;TGFB2	0.133649163058407
222	GO:0060571	0.00973025248515336	14.9806201550388	0.150414494487651	2	20	morphogenesis of an epithelial fold	RDH10;WNT5A	0.133649163058407
223	GO:0071634	0.00973025248515336	14.9806201550388	0.150414494487651	2	20	regulation of transforming growth factor beta production	LUM;TGFB2	0.133649163058407
224	GO:0051781	0.00986668923172513	7.28382352941177	0.443722758738569	3	59	positive regulation of cell division	FGF2;PTN;TGFB2	0.134918165699884
225	GO:0060562	0.0102959441451284	3.48219206041433	1.84257755747372	6	245	epithelial tube morphogenesis	FGF2;RBM15;RDH10;SOX4;TGFB2;WNT5A	0.140008636639731
226	GO:1901216	0.0103303793276458	7.15541795665635	0.451243483462952	3	60	positive regulation of neuron death	BCL2L11;TGFB2;WNT5A	0.140008636639731
227	GO:0019725	0.0104501091526873	2.40945054945055	4.97119904281685	11	661	cellular homeostasis	CYBRD1;FGF2;GSTO1;ITGAV;LPAR4;PDGFRA;RAB39A;SLC30A1;SLC4A7;SOX4;TRA2B	0.141007419976569
228	GO:0003006	0.010648538253726	2.65966085502747	3.65507221604991	9	486	developmental process involved in reproduction	BCL2L11;FBXO5;FNDC3A;ID4;PDGFRA;RBM15;RDH10;TGFB2;WNT5A	0.141909912338133
229	GO:0021537	0.0106806527483284	4.00707481087139	1.33116827621571	5	177	telencephalon development	GNG12;ID4;SALL3;TRA2B;WNT5A	0.141909912338133
230	GO:0043516	0.0107023146425429	14.1909424724602	0.157935219212033	2	21	regulation of DNA damage response, signal transduction by p53 class mediator	DYRK3;SPRED1	0.141909912338133
231	GO:0071604	0.0107023146425429	14.1909424724602	0.157935219212033	2	21	transforming growth factor beta production	LUM;TGFB2	0.141909912338133
232	GO:0034637	0.0108065562245642	7.03144016227181	0.458764208187334	3	61	cellular carbohydrate biosynthetic process	CSGALNACT2;HAS2;PGM2	0.142485606587368
233	GO:0051716	0.0108424917082418	1.67447728911319	38.8069395778139	50	5160	cellular response to stimulus	ABI1;ACAA2;ANOS1;AQP4;AQR;ASPN;BCL2L11;CASP7;CSNK1A1;DYRK3;EDEM3;FERMT2;FGF2;FIBIN;FKBP14;GNB4;GNG12;GSTO1;HAS2;IL33;ITGAV;KLHL15;LGALS3;LPAR4;MAP3K2;MBD2;NAMPT;OSGIN2;PAWR;PDGFRA;PIK3C2A;PLSCR4;PTN;PTPRZ1;RAB39A;RBM15;RHOQ;RND3;RNF139;SALL3;SCYL2;SOCS4;SOX4;SPRED1;SS18;STK17B;TGFB2;TRA2B;TSPAN12;WNT5A	0.142485606587368
234	GO:0035148	0.0109648544759476	4.93436293436293	0.864883343303991	4	115	tube formation	BCL2L11;SOX4;TGFB2;WNT5A	0.142485606587368
235	GO:0010594	0.0112925969502652	4.88988095238095	0.872404068028374	4	116	regulation of endothelial cell migration	FGF2;PIK3C2A;SPRED1;WNT5A	0.142485606587368
236	GO:0046661	0.0112925969502652	4.88988095238095	0.872404068028374	4	116	male sex differentiation	BCL2L11;FNDC3A;TGFB2;WNT5A	0.142485606587368
237	GO:0045778	0.0112952796019849	6.91166500498504	0.466284932911717	3	62	positive regulation of ossification	ID4;TGFB2;WNT5A	0.142485606587368
238	GO:0016331	0.0116266010819938	4.84618626211547	0.879924792752756	4	117	morphogenesis of embryonic epithelium	RDH10;SOX4;TGFB2;WNT5A	0.142485606587368
239	GO:0048754	0.0116266010819938	4.84618626211547	0.879924792752756	4	117	branching morphogenesis of an epithelial tube	FGF2;RBM15;RDH10;WNT5A	0.142485606587368
240	GO:0060041	0.0116266010819938	4.84618626211547	0.879924792752756	4	117	retina development in camera-type eye	PDGFRA;PTN;TGFB2;TSPAN12	0.142485606587368
241	GO:0071695	0.0116266010819938	4.84618626211547	0.879924792752756	4	117	anatomical structure maturation	FBXO5;PTBP3;TGFB2;WNT5A	0.142485606587368
242	GO:0032958	0.011715464735472	13.4802325581395	0.165455943936416	2	22	inositol phosphate biosynthetic process	FGF2;IPMK	0.142485606587368
243	GO:0040020	0.011715464735472	13.4802325581395	0.165455943936416	2	22	regulation of meiotic nuclear division	FBXO5;WNT5A	0.142485606587368
244	GO:0060740	0.011715464735472	13.4802325581395	0.165455943936416	2	22	prostate gland epithelium morphogenesis	ID4;WNT5A	0.142485606587368
245	GO:0001570	0.0117966056236485	6.79588235294118	0.473805657636099	3	63	vasculogenesis	HAS2;ITGAV;SPRED1	0.142485606587368
246	GO:0048856	0.0120316231723128	1.66429582972247	31.2561319545338	42	4156	anatomical structure development	ABI1;ANOS1;ASPH;ASPN;BCL2L11;CSNK1A1;DYRK3;FBXO5;FERMT2;FGF2;FNDC3A;GNB4;GNG12;HAS2;ID4;IL33;ITGAV;KBTBD8;LGALS3;LUM;MARCH7;MBD2;PDGFRA;PIK3C2A;PTBP3;PTN;PTPRZ1;RBM15;RDH10;RHOQ;RND3;SALL3;SLC30A1;SLC4A7;SLC7A11;SOX4;SPRED1;SS18;TGFB2;TRA2B;TSPAN12;WNT5A	0.142485606587368
247	GO:1901617	0.0122088968215595	3.86997427913903	1.376292624562	5	183	organic hydroxy compound biosynthetic process	ACAA2;FGF2;IPMK;TGFB2;WNT5A	0.142485606587368
248	GO:0010604	0.0127092009389084	1.77136389360498	16.9141099051363	26	2249	positive regulation of macromolecule metabolic process	ABI1;ASPH;BCL2L11;CASP7;CSNK1A1;FBXO5;FGF2;HAS2;ID4;IL33;ITGAV;LUM;MAP3K2;NAMPT;PAWR;PDGFRA;RBM15;RHOQ;RNF139;SCYL2;SOCS4;SOX4;SS18;TGFB2;TRA2B;WNT5A	0.142485606587368
249	GO:0003171	0.0127690443333714	12.8372093023256	0.172976668660798	2	23	atrioventricular valve development	SOX4;TGFB2	0.142485606587368
250	GO:0003401	0.0127690443333714	12.8372093023256	0.172976668660798	2	23	axis elongation	RDH10;WNT5A	0.142485606587368
251	GO:0006517	0.0127690443333714	12.8372093023256	0.172976668660798	2	23	protein deglycosylation	EDEM3;RNF139	0.142485606587368
252	GO:0021772	0.0127690443333714	12.8372093023256	0.172976668660798	2	23	olfactory bulb development	SALL3;WNT5A	0.142485606587368
253	GO:0042044	0.0127690443333714	12.8372093023256	0.172976668660798	2	23	fluid transport	AQP4;HAS2	0.142485606587368
254	GO:0042634	0.0127690443333714	12.8372093023256	0.172976668660798	2	23	regulation of hair cycle	TGFB2;WNT5A	0.142485606587368
255	GO:0044068	0.0127690443333714	12.8372093023256	0.172976668660798	2	23	modulation by symbiont of host cellular process	BCL2L11;ITGAV	0.142485606587368
256	GO:0060512	0.0127690443333714	12.8372093023256	0.172976668660798	2	23	prostate gland morphogenesis	ID4;WNT5A	0.142485606587368
257	GO:0003007	0.013026136939192	3.80483259002862	1.39885479873515	5	186	heart morphogenesis	HAS2;RBM15;SOX4;TGFB2;WNT5A	0.142485606587368
258	GO:0002520	0.0131274824729999	2.32589285714286	5.13665498675327	11	683	immune system development	ABI1;BCL2L11;DYRK3;LGALS3;MARCH7;PTBP3;PTPRZ1;RBM15;SOX4;TGFB2;WNT5A	0.142485606587368
259	GO:0032502	0.0131954165669063	1.64774281805746	33.3168105290146	44	4430	developmental process	ABI1;ANOS1;ASPH;ASPN;BCL2L11;CSNK1A1;DYRK3;FBXO5;FERMT2;FGF2;FNDC3A;GNB4;GNG12;HAS2;ID4;IL33;ITGAV;KBTBD8;LGALS3;LUM;MARCH7;MBD2;PAWR;PDGFRA;PIK3C2A;PTBP3;PTN;PTPRZ1;RBM15;RDH10;RHOQ;RND3;SALL3;SLC30A1;SLC4A7;SLC7A11;SOX4;SPRED1;SS18;SUZ12;TGFB2;TRA2B;TSPAN12;WNT5A	0.142485606587368
260	GO:0060021	0.0133767097478081	6.47058823529412	0.496367831809247	3	66	roof of mouth development	ASPH;TGFB2;WNT5A	0.142485606587368
261	GO:0021953	0.013391997253486	4.63882163034705	0.917528416374669	4	122	central nervous system neuron differentiation	ID4;SALL3;SOX4;WNT5A	0.142485606587368
262	GO:0035967	0.013391997253486	4.63882163034705	0.917528416374669	4	122	cellular response to topologically incorrect protein	BCL2L11;EDEM3;FKBP14;KLHL15	0.142485606587368
263	GO:0030162	0.0137570979671346	2.54270245539119	3.81300743526194	9	507	regulation of proteolysis	ANOS1;ASPH;BCL2L11;CASP7;CFI;CSNK1A1;IL33;RNF139;SOCS4	0.142485606587368
264	GO:0030203	0.0137644311882006	4.59943977591036	0.925049141099051	4	123	glycosaminoglycan metabolic process	CSGALNACT2;FGF2;HAS2;LUM	0.142485606587368
265	GO:0002701	0.0138624023884305	12.2526427061311	0.180497393385181	2	24	negative regulation of production of molecular mediator of immune response	IL33;TGFB2	0.142485606587368
266	GO:0010863	0.0138624023884305	12.2526427061311	0.180497393385181	2	24	positive regulation of phospholipase C activity	FGF2;PDGFRA	0.142485606587368
267	GO:0021988	0.0138624023884305	12.2526427061311	0.180497393385181	2	24	olfactory lobe development	SALL3;WNT5A	0.142485606587368
268	GO:0031365	0.0138624023884305	12.2526427061311	0.180497393385181	2	24	N-terminal protein amino acid modification	NAA50;SOX4	0.142485606587368
269	GO:0070232	0.0138624023884305	12.2526427061311	0.180497393385181	2	24	regulation of T cell apoptotic process	LGALS3;WNT5A	0.142485606587368
270	GO:0090279	0.0138624023884305	12.2526427061311	0.180497393385181	2	24	regulation of calcium ion import	LGALS3;SLC30A1	0.142485606587368
271	GO:0031325	0.0138889489842988	1.75570891382962	17.0344415007264	26	2265	positive regulation of cellular metabolic process	ABI1;ASPH;BCL2L11;CASP7;CSNK1A1;FBXO5;FGF2;HAS2;ID4;IL33;ITGAV;LUM;MAP3K2;NAMPT;PAWR;PDGFRA;RBM15;RHOQ;RNF139;SCYL2;SOCS4;SOX4;SS18;TGFB2;TRA2B;WNT5A	0.142485606587368
272	GO:0048145	0.0139289398157363	6.36893382352941	0.50388855653363	3	67	regulation of fibroblast proliferation	PAWR;PDGFRA;WNT5A	0.142485606587368
273	GO:0048869	0.0141143905012055	1.68227972486079	23.2089564994445	33	3086	cellular developmental process	ABI1;ANOS1;CSNK1A1;DYRK3;FBXO5;FERMT2;FGF2;FNDC3A;HAS2;ID4;IL33;ITGAV;KBTBD8;LGALS3;LUM;PAWR;PDGFRA;PTBP3;PTN;PTPRZ1;RBM15;RDH10;RHOQ;RND3;SALL3;SLC4A7;SLC7A11;SOX4;SPRED1;SS18;SUZ12;TGFB2;WNT5A	0.142485606587368
274	GO:0060326	0.0141724510221223	3.72126343210681	1.42893769763268	5	190	cell chemotaxis	FGF2;LGALS3;PDGFRA;TGFB2;WNT5A	0.142485606587368
275	GO:0060485	0.0141724510221223	3.72126343210681	1.42893769763268	5	190	mesenchyme development	HAS2;KBTBD8;RDH10;TGFB2;WNT5A	0.142485606587368
276	GO:0048144	0.0144940027462076	6.270407239819	0.511409281258012	3	68	fibroblast proliferation	PAWR;PDGFRA;WNT5A	0.142485606587368
277	GO:0007417	0.0145054134507702	2.28969417679095	5.21186223399709	11	693	central nervous system development	BCL2L11;GNB4;GNG12;ID4;PTN;PTPRZ1;SALL3;SLC7A11;SOX4;TRA2B;WNT5A	0.142485606587368
278	GO:0055080	0.0145878620377222	2.51629463723985	3.85061105888386	9	512	cation homeostasis	CYBRD1;FGF2;GSTO1;ITGAV;LPAR4;PDGFRA;RAB39A;SLC30A1;SLC4A7	0.142485606587368
279	GO:0060429	0.0146239154707805	2.13506116207951	6.65584138107854	13	885	epithelium development	ABI1;FGF2;FNDC3A;ID4;LGALS3;PTN;RBM15;RDH10;SLC4A7;SLC7A11;SOX4;TGFB2;WNT5A	0.142485606587368
280	GO:0002282	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	microglial cell activation involved in immune response	IL33	0.142485606587368
281	GO:0003213	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	cardiac right atrium morphogenesis	WNT5A	0.142485606587368
282	GO:0007056	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	spindle assembly involved in female meiosis	FBXO5	0.142485606587368
283	GO:0007057	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	spindle assembly involved in female meiosis I	FBXO5	0.142485606587368
284	GO:0034087	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	establishment of mitotic sister chromatid cohesion	NAA50	0.142485606587368
285	GO:0035617	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	stress granule disassembly	DYRK3	0.142485606587368
286	GO:0036518	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	chemorepulsion of dopaminergic neuron axon	WNT5A	0.142485606587368
287	GO:0038172	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	interleukin-33-mediated signaling pathway	IL33	0.142485606587368
288	GO:0042264	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	peptidyl-aspartic acid hydroxylation	ASPH	0.142485606587368
289	GO:0042704	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	uterine wall breakdown	TGFB2	0.142485606587368
290	GO:0042986	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	positive regulation of amyloid precursor protein biosynthetic process	PAWR	0.142485606587368
291	GO:0044533	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	positive regulation of apoptotic process in other organism	BCL2L11	0.142485606587368
292	GO:0045715	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	negative regulation of low-density lipoprotein particle receptor biosynthetic process	ITGAV	0.142485606587368
293	GO:0046946	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	hydroxylysine metabolic process	PLOD2	0.142485606587368
294	GO:0046947	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	hydroxylysine biosynthetic process	PLOD2	0.142485606587368
295	GO:0050653	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process	CSGALNACT2	0.142485606587368
296	GO:0051795	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	positive regulation of timing of catagen	TGFB2	0.142485606587368
297	GO:0052042	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	positive regulation by symbiont of host programmed cell death	BCL2L11	0.142485606587368
298	GO:0052151	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	positive regulation by symbiont of host apoptotic process	BCL2L11	0.142485606587368
299	GO:0052330	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction	BCL2L11	0.142485606587368
300	GO:0052501	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction	BCL2L11	0.142485606587368
301	GO:0060031	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	mediolateral intercalation	WNT5A	0.142485606587368
302	GO:0060067	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	cervix development	WNT5A	0.142485606587368
303	GO:0060139	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	positive regulation of apoptotic process by virus	BCL2L11	0.142485606587368
304	GO:0060221	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	retinal rod cell differentiation	PTN	0.142485606587368
305	GO:0060591	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	chondroblast differentiation	FGF2	0.142485606587368
306	GO:0060741	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	prostate gland stromal morphogenesis	ID4	0.142485606587368
307	GO:0060775	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	planar cell polarity pathway involved in gastrula mediolateral intercalation	WNT5A	0.142485606587368
308	GO:0061341	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	non-canonical Wnt signaling pathway involved in heart development	WNT5A	0.142485606587368
309	GO:0061346	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	planar cell polarity pathway involved in heart morphogenesis	WNT5A	0.142485606587368
310	GO:0061517	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	macrophage proliferation	IL33	0.142485606587368
311	GO:0061518	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	microglial cell proliferation	IL33	0.142485606587368
312	GO:0097325	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	melanocyte proliferation	WNT5A	0.142485606587368
313	GO:1902109	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	negative regulation of mitochondrial membrane permeability involved in apoptotic process	ACAA2	0.142485606587368
314	GO:1902263	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	apoptotic process involved in embryonic digit morphogenesis	BCL2L11	0.142485606587368
315	GO:1904397	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	negative regulation of neuromuscular junction development	PTN	0.142485606587368
316	GO:1904862	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	inhibitory synapse assembly	WNT5A	0.142485606587368
317	GO:1905006	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	TGFB2	0.142485606587368
318	GO:2000521	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	negative regulation of immunological synapse formation	LGALS3	0.142485606587368
319	GO:2001188	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	LGALS3	0.142485606587368
320	GO:2001189	0.0149855261110707	133.471264367816	0.0150414494487651	1	2	negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	LGALS3	0.142485606587368
321	GO:1900274	0.014994895163855	11.7189079878665	0.188018118109563	2	25	regulation of phospholipase C activity	FGF2;PDGFRA	0.142485606587368
322	GO:1902742	0.014994895163855	11.7189079878665	0.188018118109563	2	25	apoptotic process involved in development	BCL2L11;TGFB2	0.142485606587368
323	GO:0071887	0.0150719348789772	6.17486631016043	0.518930005982395	3	69	leukocyte apoptotic process	BCL2L11;LGALS3;WNT5A	0.142485606587368
324	GO:1901800	0.0150719348789772	6.17486631016043	0.518930005982395	3	69	positive regulation of proteasomal protein catabolic process	CSNK1A1;IL33;SOCS4	0.142485606587368
325	GO:0007165	0.0155176091954173	1.62846512985118	31.692333988548	42	4214	signal transduction	ABI1;ACAA2;ANOS1;ASPN;BCL2L11;CSNK1A1;DYRK3;EDEM3;FERMT2;FGF2;FIBIN;FKBP14;GNB4;GNG12;GSTO1;IL33;ITGAV;LGALS3;LPAR4;MAP3K2;MBD2;NAMPT;OSGIN2;PAWR;PDGFRA;PIK3C2A;PTN;PTPRZ1;RAB39A;RBM15;RHOQ;RND3;SALL3;SCYL2;SOCS4;SOX4;SPRED1;SS18;STK17B;TGFB2;TSPAN12;WNT5A	0.146247498355579
326	GO:0010595	0.0156627694542858	6.08217734855136	0.526450730706777	3	70	positive regulation of endothelial cell migration	FGF2;PIK3C2A;WNT5A	0.146265435483163
327	GO:0034446	0.0156627694542858	6.08217734855136	0.526450730706777	3	70	substrate adhesion-dependent cell spreading	FERMT2;HAS2;ITGAV	0.146265435483163
328	GO:0044264	0.0156627694542858	6.08217734855136	0.526450730706777	3	70	cellular polysaccharide metabolic process	CSGALNACT2;HAS2;PGM2	0.146265435483163
329	GO:0007420	0.015812916467611	2.48019359642591	3.90325613195453	9	519	brain development	BCL2L11;GNB4;GNG12;ID4;PTN;SALL3;SLC7A11;TRA2B;WNT5A	0.14682446769255
330	GO:0051173	0.0158185028855833	1.74658545588778	16.357576275532	25	2175	positive regulation of nitrogen compound metabolic process	ABI1;ASPH;BCL2L11;CASP7;CSNK1A1;FBXO5;FGF2;HAS2;ID4;IL33;ITGAV;LUM;MAP3K2;NAMPT;PAWR;PDGFRA;RBM15;RHOQ;RNF139;SOCS4;SOX4;SS18;TGFB2;TRA2B;WNT5A	0.14682446769255
331	GO:0003091	0.0161658861627675	11.2296511627907	0.195538842833946	2	26	renal water homeostasis	AQP4;HAS2	0.147410848770268
332	GO:0010464	0.0161658861627675	11.2296511627907	0.195538842833946	2	26	regulation of mesenchymal cell proliferation	PTN;WNT5A	0.147410848770268
333	GO:0035909	0.0161658861627675	11.2296511627907	0.195538842833946	2	26	aorta morphogenesis	SOX4;TGFB2	0.147410848770268
334	GO:0043552	0.0161658861627675	11.2296511627907	0.195538842833946	2	26	positive regulation of phosphatidylinositol 3-kinase activity	FGF2;PDGFRA	0.147410848770268
335	GO:0070528	0.0161658861627675	11.2296511627907	0.195538842833946	2	26	protein kinase C signaling	FIBIN;WNT5A	0.147410848770268
336	GO:0022414	0.0161704359081978	2.04813673143612	7.490641825485	14	996	reproductive process	BCL2L11;FBXO5;FNDC3A;HAS2;ID4;MBD2;NAMPT;OSGIN2;PDGFRA;PTN;RBM15;RDH10;TGFB2;WNT5A	0.147410848770268
337	GO:0043535	0.0162665366692538	5.99221453287197	0.53397145543116	3	71	regulation of blood vessel endothelial cell migration	FGF2;PIK3C2A;SPRED1	0.147846889667431
338	GO:0098771	0.016360627853362	2.46502331778814	3.92581830612768	9	522	inorganic ion homeostasis	CYBRD1;FGF2;GSTO1;ITGAV;LPAR4;PDGFRA;RAB39A;SLC30A1;SLC4A7	0.148262139393041
339	GO:0000003	0.0164307217729052	2.04358932102835	7.50568327493377	14	998	reproduction	BCL2L11;FBXO5;FNDC3A;HAS2;ID4;MBD2;NAMPT;OSGIN2;PDGFRA;PTN;RBM15;RDH10;TGFB2;WNT5A	0.148458114425984
340	GO:0048523	0.0170809735686928	1.64054141263183	25.3298008717204	35	3368	negative regulation of cellular process	ABI1;ACAA2;ANOS1;ASPH;ASPN;BTG3;CSNK1A1;DYRK3;FBXO5;FGF2;GSTO1;ID4;IL33;ITGAV;KLHL15;LGALS3;MARCH7;MBD2;OSGIN2;PAWR;PDGFRA;PTBP3;PTN;RBM15;RNF139;SALL3;SCYL2;SLC30A1;SOCS4;SOX4;SPRED1;SUZ12;TGFB2;TRA2B;WNT5A	0.153879476590901
341	GO:0043065	0.0172664857406529	2.59443155452436	3.30159815400393	8	439	positive regulation of apoptotic process	BCL2L11;CASP7;PAWR;PTN;SOX4;STK17B;TGFB2;WNT5A	0.155094562532609
342	GO:0048536	0.0173747460577442	10.7795348837209	0.203059567558328	2	27	spleen development	BCL2L11;RBM15	0.155156988848019
343	GO:0048566	0.0173747460577442	10.7795348837209	0.203059567558328	2	27	embryonic digestive tract development	PDGFRA;TGFB2	0.155156988848019
344	GO:0050868	0.0175129749242323	5.82	0.549012904879925	3	73	negative regulation of T cell activation	LGALS3;MARCH7;PAWR	0.155936750560824
345	GO:0050679	0.0178543769025139	4.23920265780731	1.00025638834288	4	133	positive regulation of epithelial cell proliferation	FGF2;HAS2;PTN;WNT5A	0.156968693656754
346	GO:0043068	0.0181338455096653	2.56965517241379	3.33168105290146	8	443	positive regulation of programmed cell death	BCL2L11;CASP7;PAWR;PTN;SOX4;STK17B;TGFB2;WNT5A	0.156968693656754
347	GO:0048598	0.0181338455096653	2.56965517241379	3.33168105290146	8	443	embryonic morphogenesis	BCL2L11;FGF2;ITGAV;PDGFRA;RDH10;SOX4;TGFB2;WNT5A	0.156968693656754
348	GO:0001667	0.0182159986210851	3.05084289813486	2.09076147337834	6	278	ameboidal-type cell migration	FGF2;HAS2;PIK3C2A;SPRED1;TGFB2;WNT5A	0.156968693656754
349	GO:0003205	0.0183006684924768	4.20622710622711	1.00777711306726	4	134	cardiac chamber development	RBM15;SOX4;TGFB2;WNT5A	0.156968693656754
350	GO:0050866	0.0183006684924768	4.20622710622711	1.00777711306726	4	134	negative regulation of cell activation	LGALS3;MARCH7;PAWR;PDGFRA	0.156968693656754
351	GO:0030900	0.0185068746672695	3.03939962476548	2.09828219810273	6	279	forebrain development	GNG12;ID4;PTN;SALL3;TRA2B;WNT5A	0.156968693656754
352	GO:0043537	0.0186208526209838	10.3640429338104	0.210580292282711	2	28	negative regulation of blood vessel endothelial cell migration	FGF2;SPRED1	0.156968693656754
353	GO:0045684	0.0186208526209838	10.3640429338104	0.210580292282711	2	28	positive regulation of epidermis development	TGFB2;WNT5A	0.156968693656754
354	GO:0050856	0.0186208526209838	10.3640429338104	0.210580292282711	2	28	regulation of T cell receptor signaling pathway	LGALS3;PAWR	0.156968693656754
355	GO:0060317	0.0186208526209838	10.3640429338104	0.210580292282711	2	28	cardiac epithelial to mesenchymal transition	HAS2;TGFB2	0.156968693656754
356	GO:0090218	0.0186208526209838	10.3640429338104	0.210580292282711	2	28	positive regulation of lipid kinase activity	FGF2;PDGFRA	0.156968693656754
357	GO:0006022	0.0187538652927259	4.17375499818248	1.01529783779164	4	135	aminoglycan metabolic process	CSGALNACT2;FGF2;HAS2;LUM	0.156968693656754
358	GO:0002700	0.0188114324550062	5.65735294117647	0.56405435432869	3	75	regulation of production of molecular mediator of immune response	IL33;TGFB2;WNT5A	0.156968693656754
359	GO:0022604	0.0193402831336604	2.73266056318491	2.73002307495086	7	363	regulation of cell morphogenesis	CSNK1A1;FERMT2;HAS2;PTN;RHOQ;RND3;WNT5A	0.156968693656754
360	GO:1903317	0.0194802131707186	5.57937147461724	0.571575079053072	3	76	regulation of protein maturation	CFI;RNF139;SOX4	0.156968693656754
361	GO:1901028	0.0199035906551024	9.97932816537468	0.218101017007093	2	29	regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	ACAA2;BCL2L11	0.156968693656754
362	GO:1903672	0.0199035906551024	9.97932816537468	0.218101017007093	2	29	positive regulation of sprouting angiogenesis	FGF2;PIK3C2A	0.156968693656754
363	GO:0010923	0.0201620468689557	5.50349761526232	0.579095803777455	3	77	negative regulation of phosphatase activity	PTN;SPRED1;TGFB2	0.156968693656754
364	GO:0043412	0.020341041754218	1.62542318748004	23.7955730279463	33	3164	macromolecule modification	ABI1;ASPH;ASPN;CSNK1A1;DPY19L3;DYRK3;EDEM3;FBXO5;FGF2;FKBP14;IL33;ITGAV;KBTBD8;KLHL15;MAP3K2;MARCH7;MBD2;NAA50;PDGFRA;PLOD2;PTN;PTPRZ1;RNF139;SCYL2;SOCS4;SOX4;SPRED1;STK17B;SUZ12;TGFB2;USP38;WNT5A;WTAP	0.156968693656754
365	GO:1903050	0.0206362630289349	4.04867724867725	1.04538073668917	4	139	regulation of proteolysis involved in cellular protein catabolic process	CSNK1A1;IL33;RNF139;SOCS4	0.156968693656754
366	GO:1903038	0.020856943962767	5.42964705882353	0.586616528501837	3	78	negative regulation of leukocyte cell-cell adhesion	LGALS3;MARCH7;PAWR	0.156968693656754
367	GO:0016477	0.020894370142492	1.97539608574091	7.73882574138962	14	1029	cell migration	FGF2;HAS2;IL33;ITGAV;LGALS3;PDGFRA;PIK3C2A;PTN;RHOQ;RND3;SLC7A11;SPRED1;TGFB2;WNT5A	0.156968693656754
368	GO:0051246	0.0209495313381697	1.72466440994514	15.0414494487651	23	2000	regulation of protein metabolic process	ABI1;ANOS1;ASPH;ASPN;BCL2L11;CASP7;CFI;CSNK1A1;FBXO5;FGF2;IL33;ITGAV;KBTBD8;MAP3K2;PAWR;PDGFRA;PTN;RNF139;SOCS4;SOX4;SPRED1;TGFB2;WNT5A	0.156968693656754
369	GO:0043542	0.0211243980232398	4.01855742296919	1.05290146141355	4	140	endothelial cell migration	FGF2;PIK3C2A;SPRED1;WNT5A	0.156968693656754
370	GO:1901136	0.0211243980232398	4.01855742296919	1.05290146141355	4	140	carbohydrate derivative catabolic process	EDEM3;FGF2;LUM;PGM2	0.156968693656754
371	GO:0014014	0.0212223519245496	9.62209302325581	0.225621741731476	2	30	negative regulation of gliogenesis	ID4;PTN	0.156968693656754
372	GO:0031018	0.0212223519245496	9.62209302325581	0.225621741731476	2	30	endocrine pancreas development	SOX4;WNT5A	0.156968693656754
373	GO:0046189	0.0212223519245496	9.62209302325581	0.225621741731476	2	30	phenol-containing compound biosynthetic process	TGFB2;WNT5A	0.156968693656754
374	GO:0050919	0.0212223519245496	9.62209302325581	0.225621741731476	2	30	negative chemotaxis	ITGAV;WNT5A	0.156968693656754
375	GO:0071377	0.0212223519245496	9.62209302325581	0.225621741731476	2	30	cellular response to glucagon stimulus	GNB4;GNG12	0.156968693656754
376	GO:0009966	0.0215299415703739	1.67796115695591	17.6586616528502	26	2348	regulation of signal transduction	ACAA2;ASPN;BCL2L11;CSNK1A1;DYRK3;FGF2;GSTO1;IL33;ITGAV;LGALS3;LPAR4;MAP3K2;MBD2;NAMPT;OSGIN2;PAWR;PDGFRA;PTN;RHOQ;SALL3;SCYL2;SOCS4;SOX4;SPRED1;TGFB2;WNT5A	0.156968693656754
377	GO:0002065	0.0215649122472199	5.3577399380805	0.59413725322622	3	79	columnar/cuboidal epithelial cell differentiation	SLC4A7;SOX4;WNT5A	0.156968693656754
378	GO:0002698	0.0215649122472199	5.3577399380805	0.59413725322622	3	79	negative regulation of immune effector process	IL33;LGALS3;TGFB2	0.156968693656754
379	GO:0014013	0.0215649122472199	5.3577399380805	0.59413725322622	3	79	regulation of gliogenesis	ID4;PTN;PTPRZ1	0.156968693656754
380	GO:0033554	0.0219553998831226	1.81949135704351	10.950175198701	18	1456	cellular response to stress	ACAA2;AQP4;AQR;BCL2L11;DYRK3;EDEM3;FKBP14;HAS2;KLHL15;MAP3K2;PAWR;PDGFRA;PTN;RNF139;SOX4;SPRED1;TGFB2;WNT5A	0.156968693656754
381	GO:0042592	0.0221029209744358	1.87929786463988	9.35578155713187	16	1244	homeostatic process	AQP4;BCL2L11;CYBRD1;DYRK3;FGF2;GSTO1;HAS2;ITGAV;LPAR4;PDGFRA;PTBP3;RAB39A;SLC30A1;SLC4A7;SOX4;TRA2B	0.156968693656754
382	GO:0046854	0.022285956949409	5.28770053475936	0.601657977950602	3	80	phosphatidylinositol phosphorylation	FGF2;PDGFRA;PIK3C2A	0.156968693656754
383	GO:0003274	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	endocardial cushion fusion	TGFB2	0.156968693656754
384	GO:0003275	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	apoptotic process involved in outflow tract morphogenesis	TGFB2	0.156968693656754
385	GO:0003408	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	optic cup formation involved in camera-type eye development	WNT5A	0.156968693656754
386	GO:0010693	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	negative regulation of alkaline phosphatase activity	TGFB2	0.156968693656754
387	GO:0014722	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	regulation of skeletal muscle contraction by calcium ion signaling	GSTO1	0.156968693656754
388	GO:0014809	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion	GSTO1	0.156968693656754
389	GO:0018197	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	peptidyl-aspartic acid modification	ASPH	0.156968693656754
390	GO:0021796	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	cerebral cortex regionalization	TRA2B	0.156968693656754
391	GO:0032914	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	positive regulation of transforming growth factor beta1 production	LUM	0.156968693656754
392	GO:0035790	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	platelet-derived growth factor receptor-alpha signaling pathway	PDGFRA	0.156968693656754
393	GO:0035977	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	protein deglycosylation involved in glycoprotein catabolic process	EDEM3	0.156968693656754
394	GO:0038044	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	transforming growth factor-beta secretion	ITGAV	0.156968693656754
395	GO:0038086	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	VEGF-activated platelet-derived growth factor receptor signaling pathway	PDGFRA	0.156968693656754
396	GO:0038091	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway	PDGFRA	0.156968693656754
397	GO:0042483	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	negative regulation of odontogenesis	ASPN	0.156968693656754
398	GO:0042637	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	catagen	TGFB2	0.156968693656754
399	GO:0042695	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	thelarche	WNT5A	0.156968693656754
400	GO:0045113	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	regulation of integrin biosynthetic process	TGFB2	0.156968693656754
401	GO:0045226	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	extracellular polysaccharide biosynthetic process	HAS2	0.156968693656754
402	GO:0046379	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	extracellular polysaccharide metabolic process	HAS2	0.156968693656754
403	GO:0048022	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	negative regulation of melanin biosynthetic process	WNT5A	0.156968693656754
404	GO:0048850	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	hypophysis morphogenesis	WNT5A	0.156968693656754
405	GO:0050748	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	negative regulation of lipoprotein metabolic process	ITGAV	0.156968693656754
406	GO:0051794	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	regulation of timing of catagen	TGFB2	0.156968693656754
407	GO:0060040	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	retinal bipolar neuron differentiation	PTN	0.156968693656754
408	GO:0060154	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	cellular process regulating host cell cycle in response to virus	BCL2L11	0.156968693656754
409	GO:0060686	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	negative regulation of prostatic bud formation	WNT5A	0.156968693656754
410	GO:0060744	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	mammary gland branching involved in thelarche	WNT5A	0.156968693656754
411	GO:0060750	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	epithelial cell proliferation involved in mammary gland duct elongation	WNT5A	0.156968693656754
412	GO:0061107	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	seminal vesicle development	ID4	0.156968693656754
413	GO:0061643	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	chemorepulsion of axon	WNT5A	0.156968693656754
414	GO:0061687	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	detoxification of inorganic compound	SLC30A1	0.156968693656754
415	GO:0070295	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	renal water absorption	HAS2	0.156968693656754
416	GO:0071630	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	nuclear protein quality control by the ubiquitin-proteasome system	KLHL15	0.156968693656754
417	GO:0071962	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	mitotic sister chromatid cohesion, centromeric	NAA50	0.156968693656754
418	GO:0072275	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	metanephric glomerulus morphogenesis	PDGFRA	0.156968693656754
419	GO:0072276	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	metanephric glomerulus vasculature morphogenesis	PDGFRA	0.156968693656754
420	GO:0072277	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	metanephric glomerular capillary formation	PDGFRA	0.156968693656754
421	GO:0072733	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	response to staurosporine	CASP7	0.156968693656754
422	GO:0072734	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	cellular response to staurosporine	CASP7	0.156968693656754
423	GO:0097466	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	ubiquitin-dependent glycoprotein ERAD pathway	EDEM3	0.156968693656754
424	GO:0097501	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	stress response to metal ion	SLC30A1	0.156968693656754
425	GO:1900377	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	negative regulation of secondary metabolite biosynthetic process	WNT5A	0.156968693656754
426	GO:1900623	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	regulation of monocyte aggregation	HAS2	0.156968693656754
427	GO:1900625	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	positive regulation of monocyte aggregation	HAS2	0.156968693656754
428	GO:1901029	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway	ACAA2	0.156968693656754
429	GO:1901300	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	positive regulation of hydrogen peroxide-mediated programmed cell death	PAWR	0.156968693656754
430	GO:1902256	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	regulation of apoptotic process involved in outflow tract morphogenesis	TGFB2	0.156968693656754
431	GO:1904382	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	mannose trimming involved in glycoprotein ERAD pathway	EDEM3	0.156968693656754
432	GO:1904395	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	positive regulation of skeletal muscle acetylcholine-gated channel clustering	PTN	0.156968693656754
433	GO:1904398	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	positive regulation of neuromuscular junction development	PTN	0.156968693656754
434	GO:1904849	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	positive regulation of cell chemotaxis to fibroblast growth factor	FGF2	0.156968693656754
435	GO:2000286	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	receptor internalization involved in canonical Wnt signaling pathway	SCYL2	0.156968693656754
436	GO:2000520	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	regulation of immunological synapse formation	LGALS3	0.156968693656754
437	GO:2000546	0.0223948152556322	66.7298850574713	0.0225621741731476	1	3	positive regulation of endothelial cell chemotaxis to fibroblast growth factor	FGF2	0.156968693656754
438	GO:0023052	0.0225669390449853	1.57209302325581	34.28698401846	44	4559	signaling	ABI1;ACAA2;ANOS1;ASPH;ASPN;BCL2L11;CSNK1A1;DYRK3;EDEM3;FERMT2;FGF2;FIBIN;FKBP14;GNB4;GNG12;GSTO1;IL33;ITGAV;LGALS3;LPAR4;MAP3K2;MBD2;NAMPT;OSGIN2;PAWR;PDGFRA;PIK3C2A;PTN;PTPRZ1;RAB39A;RBM15;RHOQ;RND3;SALL3;SCYL2;SLC30A1;SOCS4;SOX4;SPRED1;SS18;STK17B;TGFB2;TSPAN12;WNT5A	0.157163470394184
439	GO:0035136	0.0225765350876398	9.28949478748998	0.233142466455858	2	31	forelimb morphogenesis	RDH10;SALL3	0.157163470394184
440	GO:0043030	0.0225765350876398	9.28949478748998	0.233142466455858	2	31	regulation of macrophage activation	IL33;WNT5A	0.157163470394184
441	GO:0005976	0.0230200807777969	5.21945701357466	0.609178702674985	3	81	polysaccharide metabolic process	CSGALNACT2;HAS2;PGM2	0.159887771932862
442	GO:0061138	0.0231478207092311	3.90238095238095	1.08298436031108	4	144	morphogenesis of a branching epithelium	FGF2;RBM15;RDH10;WNT5A	0.160411255276867
443	GO:0048534	0.0234900308957898	2.20175755387023	4.88095034612426	10	649	hematopoietic or lymphoid organ development	ABI1;BCL2L11;DYRK3;LGALS3;PTBP3;PTPRZ1;RBM15;SOX4;TGFB2;WNT5A	0.162415270053734
444	GO:0006024	0.0237672839708914	5.15294117647059	0.616699427399368	3	82	glycosaminoglycan biosynthetic process	CSGALNACT2;HAS2;LUM	0.163226885208162
445	GO:0035305	0.0237672839708914	5.15294117647059	0.616699427399368	3	82	negative regulation of dephosphorylation	PTN;SPRED1;TGFB2	0.163226885208162
446	GO:0043534	0.0237672839708914	5.15294117647059	0.616699427399368	3	82	blood vessel endothelial cell migration	FGF2;PIK3C2A;SPRED1	0.163226885208162
447	GO:0008380	0.0239506224802044	2.8569386038688	2.22613451841723	6	296	RNA splicing	AQR;LGALS3;PTBP3;RBM15;TRA2B;WTAP	0.16385371933532
448	GO:0030212	0.0239655456291947	8.97906976744186	0.240663191180241	2	32	hyaluronan metabolic process	FGF2;HAS2	0.16385371933532
449	GO:0035966	0.0242023780521416	3.84674714956405	1.09802580975985	4	146	response to topologically incorrect protein	BCL2L11;EDEM3;FKBP14;KLHL15	0.165104418649688
450	GO:0001841	0.0245275643452678	5.08808823529412	0.62422015212375	3	83	neural tube formation	SOX4;TGFB2;WNT5A	0.166025367385728
451	GO:0016525	0.0245275643452678	5.08808823529412	0.62422015212375	3	83	negative regulation of angiogenesis	PTN;SPRED1;TGFB2	0.166025367385728
452	GO:0032434	0.0245275643452678	5.08808823529412	0.62422015212375	3	83	regulation of proteasomal ubiquitin-dependent protein catabolic process	CSNK1A1;IL33;SOCS4	0.166025367385728
453	GO:0007204	0.0245541924341282	3.20881657471006	1.64703871463977	5	219	positive regulation of cytosolic calcium ion concentration	FGF2;GSTO1;ITGAV;LPAR4;PDGFRA	0.166025367385728
454	GO:0002683	0.0246548152963308	2.8368693618443	2.24117596786599	6	298	negative regulation of immune system process	IL33;LGALS3;MARCH7;PAWR;RBM15;TGFB2	0.166338544609386
455	GO:0002040	0.0253009173429447	5.02483660130719	0.631740876848133	3	84	sprouting angiogenesis	FGF2;PIK3C2A;SPRED1	0.168324418866621
456	GO:2000181	0.0253009173429447	5.02483660130719	0.631740876848133	3	84	negative regulation of blood vessel morphogenesis	PTN;SPRED1;TGFB2	0.168324418866621
457	GO:0000381	0.0253887957937901	8.68867216804201	0.248183915904624	2	33	regulation of alternative mRNA splicing, via spliceosome	TRA2B;WTAP	0.168324418866621
458	GO:0003179	0.0253887957937901	8.68867216804201	0.248183915904624	2	33	heart valve morphogenesis	SOX4;TGFB2	0.168324418866621
459	GO:0007257	0.0253887957937901	8.68867216804201	0.248183915904624	2	33	activation of JUN kinase activity	MAP3K2;WNT5A	0.168324418866621
460	GO:0010799	0.0253887957937901	8.68867216804201	0.248183915904624	2	33	regulation of peptidyl-threonine phosphorylation	SPRED1;WNT5A	0.168324418866621
461	GO:0044003	0.0253887957937901	8.68867216804201	0.248183915904624	2	33	modification by symbiont of host morphology or physiology	BCL2L11;ITGAV	0.168324418866621
462	GO:0048701	0.0253887957937901	8.68867216804201	0.248183915904624	2	33	embryonic cranial skeleton morphogenesis	PDGFRA;RDH10	0.168324418866621
463	GO:0030330	0.0260873360781179	4.96312769010043	0.639261601572515	3	85	DNA damage response, signal transduction by p53 class mediator	DYRK3;SOX4;SPRED1	0.169362382327716
464	GO:0072089	0.0260873360781179	4.96312769010043	0.639261601572515	3	85	stem cell proliferation	FGF2;ID4;WNT5A	0.169362382327716
465	GO:0050801	0.0260907177713411	2.26130036588414	4.25673019400051	9	566	ion homeostasis	CYBRD1;FGF2;GSTO1;ITGAV;LPAR4;PDGFRA;RAB39A;SLC30A1;SLC4A7	0.169362382327716
466	GO:0010942	0.026525899757083	2.38141025641026	3.57986496880608	8	476	positive regulation of cell death	BCL2L11;CASP7;PAWR;PTN;SOX4;STK17B;TGFB2;WNT5A	0.169362382327716
467	GO:0023051	0.0265657210645974	1.62012578616352	19.7419024015041	28	2625	regulation of signaling	ACAA2;ASPH;ASPN;BCL2L11;CSNK1A1;DYRK3;FGF2;GSTO1;IL33;ITGAV;LGALS3;LPAR4;MAP3K2;MBD2;NAMPT;OSGIN2;PAWR;PDGFRA;PTN;RHOQ;SALL3;SCYL2;SLC30A1;SOCS4;SOX4;SPRED1;TGFB2;WNT5A	0.169362382327716
468	GO:0010463	0.0268457045196036	8.41642441860465	0.255704640629006	2	34	mesenchymal cell proliferation	PTN;WNT5A	0.169362382327716
469	GO:0022602	0.0268457045196036	8.41642441860465	0.255704640629006	2	34	ovulation cycle process	PDGFRA;TGFB2	0.169362382327716
470	GO:0036092	0.0268457045196036	8.41642441860465	0.255704640629006	2	34	phosphatidylinositol-3-phosphate biosynthetic process	FGF2;PIK3C2A	0.169362382327716
471	GO:0051445	0.0268457045196036	8.41642441860465	0.255704640629006	2	34	regulation of meiotic cell cycle	FBXO5;WNT5A	0.169362382327716
472	GO:1903727	0.0268457045196036	8.41642441860465	0.255704640629006	2	34	positive regulation of phospholipid metabolic process	FGF2;PDGFRA	0.169362382327716
473	GO:0097435	0.0274042143500142	2.3656050955414	3.60242714297923	8	479	supramolecular fiber organization	ABI1;FBXO5;LUM;PAWR;PDGFRA;RHOQ;RND3;TGFB2	0.169362382327716
474	GO:0051271	0.0276399988237417	3.10527176579622	1.69968378771045	5	226	negative regulation of cellular component movement	FGF2;IL33;PTN;SPRED1;WNT5A	0.169362382327716
475	GO:1901700	0.0276596630907308	1.85695172920046	8.81428937697633	15	1172	response to oxygen-containing compound	EDEM3;FIBIN;GNB4;GNG12;MBD2;PAWR;PDGFRA;PIK3C2A;PLSCR4;PTN;RHOQ;SOX4;TGFB2;TRA2B;WNT5A	0.169362382327716
476	GO:0006023	0.0276993318546115	4.84411764705882	0.65430305102128	3	87	aminoglycan biosynthetic process	CSGALNACT2;HAS2;LUM	0.169362382327716
477	GO:0043484	0.0276993318546115	4.84411764705882	0.65430305102128	3	87	regulation of RNA splicing	PTBP3;TRA2B;WTAP	0.169362382327716
478	GO:0006875	0.0283181054043987	2.51356105673895	2.95564481668234	7	393	cellular metal ion homeostasis	CYBRD1;FGF2;GSTO1;ITGAV;LPAR4;PDGFRA;SLC30A1	0.169362382327716
479	GO:0043551	0.028335697372857	8.16067653276956	0.263225365353389	2	35	regulation of phosphatidylinositol 3-kinase activity	FGF2;PDGFRA	0.169362382327716
480	GO:0051926	0.028335697372857	8.16067653276956	0.263225365353389	2	35	negative regulation of calcium ion transport	GSTO1;SLC30A1	0.169362382327716
481	GO:0009893	0.0285001005657755	1.62771020624008	18.08734296214	26	2405	positive regulation of metabolic process	ABI1;ASPH;BCL2L11;CASP7;CSNK1A1;FBXO5;FGF2;HAS2;ID4;IL33;ITGAV;LUM;MAP3K2;NAMPT;PAWR;PDGFRA;RBM15;RHOQ;RNF139;SCYL2;SOCS4;SOX4;SS18;TGFB2;TRA2B;WNT5A	0.169362382327716
482	GO:0048706	0.0285248838970079	4.78671280276817	0.661823775745663	3	88	embryonic skeletal system development	PDGFRA;RDH10;WNT5A	0.169362382327716
483	GO:0001763	0.0287099401815894	3.63904761904762	1.15819160755491	4	154	morphogenesis of a branching structure	FGF2;RBM15;RDH10;WNT5A	0.169362382327716
484	GO:0065008	0.0287734795238802	1.5978174553937	20.7647209640202	29	2761	regulation of biological quality	ACAA2;AQP4;ASPH;BCL2L11;CSNK1A1;CYBRD1;DYRK3;FERMT2;FGF2;GSTO1;HAS2;ITGAV;LPAR4;PDGFRA;PIK3C2A;PLSCR4;PTBP3;PTN;RAB39A;RDH10;RHOQ;RND3;RNF139;SLC30A1;SLC4A7;SLC7A11;SOX4;TRA2B;WNT5A	0.169362382327716
485	GO:0043161	0.0291732681628841	2.72199935815148	2.33142466455858	6	310	proteasome-mediated ubiquitin-dependent protein catabolic process	CSNK1A1;EDEM3;IL33;KLHL15;RNF139;SOCS4	0.169362382327716
486	GO:1901343	0.0293634517681563	4.73064295485636	0.669344500470045	3	89	negative regulation of vasculature development	PTN;SPRED1;TGFB2	0.169362382327716
487	GO:0051235	0.0295096885495959	3.04899598393574	1.72976668660798	5	230	maintenance of location	FGF2;GSTO1;ITGAV;SLC30A1;SOX4	0.169362382327716
488	GO:0001907	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	killing by symbiont of host cells	BCL2L11	0.169362382327716
489	GO:0002291	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell	LGALS3	0.169362382327716
490	GO:0002741	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	positive regulation of cytokine secretion involved in immune response	WNT5A	0.169362382327716
491	GO:0003357	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	noradrenergic neuron differentiation	SOX4	0.169362382327716
492	GO:0008635	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c	CASP7	0.169362382327716
493	GO:0015691	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	cadmium ion transport	SLC30A1	0.169362382327716
494	GO:0018076	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	N-terminal peptidyl-lysine acetylation	SOX4	0.169362382327716
495	GO:0018103	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	protein C-linked glycosylation	DPY19L3	0.169362382327716
496	GO:0018211	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	peptidyl-tryptophan modification	DPY19L3	0.169362382327716
497	GO:0018317	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	protein C-linked glycosylation via tryptophan	DPY19L3	0.169362382327716
498	GO:0018406	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan	DPY19L3	0.169362382327716
499	GO:0035766	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	cell chemotaxis to fibroblast growth factor	FGF2	0.169362382327716
500	GO:0035768	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	endothelial cell chemotaxis to fibroblast growth factor	FGF2	0.169362382327716
501	GO:0035795	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	negative regulation of mitochondrial membrane permeability	ACAA2	0.169362382327716
502	GO:0036515	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	serotonergic neuron axon guidance	WNT5A	0.169362382327716
503	GO:0038027	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	apolipoprotein A-I-mediated signaling pathway	ITGAV	0.169362382327716
504	GO:0042640	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	anagen	WNT5A	0.169362382327716
505	GO:0044004	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	disruption by symbiont of host cell	BCL2L11	0.169362382327716
506	GO:0045112	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	integrin biosynthetic process	TGFB2	0.169362382327716
507	GO:0045136	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	development of secondary sexual characteristics	WNT5A	0.169362382327716
508	GO:0046543	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	development of secondary female sexual characteristics	WNT5A	0.169362382327716
509	GO:0048852	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	diencephalon morphogenesis	WNT5A	0.169362382327716
510	GO:0051884	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	regulation of timing of anagen	WNT5A	0.169362382327716
511	GO:0051891	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	positive regulation of cardioblast differentiation	TGFB2	0.169362382327716
512	GO:0060685	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	regulation of prostatic bud formation	WNT5A	0.169362382327716
513	GO:0060751	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	branch elongation involved in mammary gland duct branching	WNT5A	0.169362382327716
514	GO:0060762	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	regulation of branching involved in mammary gland duct morphogenesis	WNT5A	0.169362382327716
515	GO:0060979	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	vasculogenesis involved in coronary vascular morphogenesis	SPRED1	0.169362382327716
516	GO:0061343	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	cell adhesion involved in heart morphogenesis	TGFB2	0.169362382327716
517	GO:0070245	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	positive regulation of thymocyte apoptotic process	WNT5A	0.169362382327716
518	GO:0070574	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	cadmium ion transmembrane transport	SLC30A1	0.169362382327716
519	GO:0072103	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	glomerulus vasculature morphogenesis	PDGFRA	0.169362382327716
520	GO:0072104	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	glomerular capillary formation	PDGFRA	0.169362382327716
521	GO:0090306	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	spindle assembly involved in meiosis	FBXO5	0.169362382327716
522	GO:0090385	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	phagosome-lysosome fusion	RAB39A	0.169362382327716
523	GO:1900127	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	positive regulation of hyaluronan biosynthetic process	HAS2	0.169362382327716
524	GO:1904393	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	regulation of skeletal muscle acetylcholine-gated channel clustering	PTN	0.169362382327716
525	GO:1904587	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	response to glycoprotein	EDEM3	0.169362382327716
526	GO:1904847	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	regulation of cell chemotaxis to fibroblast growth factor	FGF2	0.169362382327716
527	GO:1904885	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	beta-catenin destruction complex assembly	CSNK1A1	0.169362382327716
528	GO:1905206	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	positive regulation of hydrogen peroxide-induced cell death	PAWR	0.169362382327716
529	GO:1905709	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	negative regulation of membrane permeability	ACAA2	0.169362382327716
530	GO:2000370	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	positive regulation of clathrin-dependent endocytosis	SCYL2	0.169362382327716
531	GO:2000544	0.0297490002665323	44.4827586206897	0.0300828988975301	1	4	regulation of endothelial cell chemotaxis to fibroblast growth factor	FGF2	0.169362382327716
532	GO:0010518	0.029858206482849	7.91997264021888	0.270746090077771	2	36	positive regulation of phospholipase activity	FGF2;PDGFRA	0.169362382327716
533	GO:0021879	0.029858206482849	7.91997264021888	0.270746090077771	2	36	forebrain neuron differentiation	SALL3;WNT5A	0.169362382327716
534	GO:0030199	0.029858206482849	7.91997264021888	0.270746090077771	2	36	collagen fibril organization	LUM;TGFB2	0.169362382327716
535	GO:0031076	0.029858206482849	7.91997264021888	0.270746090077771	2	36	embryonic camera-type eye development	RDH10;WNT5A	0.169362382327716
536	GO:0043525	0.029858206482849	7.91997264021888	0.270746090077771	2	36	positive regulation of neuron apoptotic process	BCL2L11;TGFB2	0.169362382327716
537	GO:0070228	0.029858206482849	7.91997264021888	0.270746090077771	2	36	regulation of lymphocyte apoptotic process	LGALS3;WNT5A	0.169362382327716
538	GO:0072132	0.029858206482849	7.91997264021888	0.270746090077771	2	36	mesenchyme morphogenesis	TGFB2;WNT5A	0.169362382327716
539	GO:0097345	0.029858206482849	7.91997264021888	0.270746090077771	2	36	mitochondrial outer membrane permeabilization	ACAA2;BCL2L11	0.169362382327716
540	GO:2000242	0.029858206482849	7.91997264021888	0.270746090077771	2	36	negative regulation of reproductive process	FBXO5;WNT5A	0.169362382327716
541	GO:0080135	0.0301609699442639	2.319375	3.67011366549868	8	488	regulation of cellular response to stress	BCL2L11;DYRK3;KLHL15;MAP3K2;PAWR;SPRED1;TGFB2;WNT5A	0.170439408797399
542	GO:0046834	0.0302150176222617	4.67586206896552	0.676865225194428	3	90	lipid phosphorylation	FGF2;PDGFRA;PIK3C2A	0.170439408797399
543	GO:0048593	0.0302150176222617	4.67586206896552	0.676865225194428	3	90	camera-type eye morphogenesis	PTN;TSPAN12;WNT5A	0.170439408797399
544	GO:0050900	0.0303829749366799	2.69468499245253	2.35398683873173	6	313	leukocyte migration	IL33;ITGAV;LGALS3;SLC7A11;TGFB2;WNT5A	0.171071787189431
545	GO:0050678	0.0304739183578747	3.02160182580542	1.74480813605675	5	232	regulation of epithelial cell proliferation	FGF2;HAS2;PTN;TGFB2;WNT5A	0.171269012715909
546	GO:0006874	0.0307934512314096	2.68569844789357	2.36150756345611	6	314	cellular calcium ion homeostasis	FGF2;GSTO1;ITGAV;LPAR4;PDGFRA;SLC30A1	0.172747877512468
547	GO:0048731	0.0308534665087507	1.55432762511616	25.4350910178617	34	3382	system development	ABI1;ANOS1;ASPN;BCL2L11;DYRK3;FGF2;FNDC3A;GNB4;GNG12;HAS2;ID4;IL33;ITGAV;KBTBD8;LGALS3;LUM;MARCH7;MBD2;PDGFRA;PIK3C2A;PTBP3;PTN;PTPRZ1;RBM15;RDH10;SALL3;SLC4A7;SLC7A11;SOX4;SPRED1;TGFB2;TRA2B;TSPAN12;WNT5A	0.172768131474046
548	GO:0051604	0.0309634262309242	3.00808497146481	1.75232886078113	5	233	protein maturation	ASPH;CFI;NAA50;RNF139;SOX4	0.17306747179803
549	GO:0003170	0.0314126704775718	7.69302325581395	0.278266814802154	2	37	heart valve development	SOX4;TGFB2	0.175258669713666
550	GO:1903362	0.0317648917448779	3.52012288786482	1.19579523117682	4	159	regulation of cellular protein catabolic process	CSNK1A1;IL33;RNF139;SOCS4	0.176863771344157
551	GO:1901701	0.0318158465591351	2.01168831168831	5.87368600974276	11	781	cellular response to oxygen-containing compound	GNB4;GNG12;PAWR;PDGFRA;PIK3C2A;PLSCR4;PTN;RHOQ;SOX4;TRA2B;WNT5A	0.176863771344157
552	GO:0006464	0.0321025893688652	1.56493571156606	22.7577130159815	31	3026	cellular protein modification process	ABI1;ASPH;ASPN;CSNK1A1;DPY19L3;DYRK3;EDEM3;FBXO5;FGF2;FKBP14;IL33;ITGAV;KBTBD8;KLHL15;MAP3K2;MARCH7;NAA50;PDGFRA;PLOD2;PTN;PTPRZ1;RNF139;SCYL2;SOCS4;SOX4;SPRED1;STK17B;SUZ12;TGFB2;USP38;WNT5A	0.177706158318842
553	GO:0036211	0.0321025893688652	1.56493571156606	22.7577130159815	31	3026	protein modification process	ABI1;ASPH;ASPN;CSNK1A1;DPY19L3;DYRK3;EDEM3;FBXO5;FGF2;FKBP14;IL33;ITGAV;KBTBD8;KLHL15;MAP3K2;MARCH7;NAA50;PDGFRA;PLOD2;PTN;PTPRZ1;RNF139;SCYL2;SOCS4;SOX4;SPRED1;STK17B;SUZ12;TGFB2;USP38;WNT5A	0.177706158318842
554	GO:0043170	0.0321414337932218	1.54540853217643	48.974959405179	58	6512	macromolecule metabolic process	ABI1;ANOS1;AQR;ASPH;ASPN;BCL2L11;CASP7;CFI;CSGALNACT2;CSNK1A1;DPY19L3;DYRK3;EDEM3;FBXO5;FGF2;FGL2;FKBP14;FYTTD1;HAS2;ID4;IL33;ITGAV;KBTBD8;KLHL15;LGALS3;LUM;MAP3K2;MARCH7;MBD2;MCMBP;MIER3;NAA50;NAMPT;NIFK;PAWR;PDGFRA;PGM2;PLOD2;PTBP3;PTN;PTPRZ1;RBM15;RHOQ;RNF139;SALL3;SCYL2;SOCS4;SOX4;SPRED1;SS18;STK17B;SUZ12;TGFB2;TRA2B;USP38;VGLL3;WNT5A;WTAP	0.177706158318842
555	GO:0051050	0.0324837021208386	2.07749287749288	5.15169643620203	10	685	positive regulation of transport	BCL2L11;GSTO1;IL33;ITGAV;LGALS3;RHOQ;SCYL2;SOX4;TGFB2;WNT5A	0.179274918191223
556	GO:0040013	0.0329710363553687	2.95518280016618	1.78241175967866	5	237	negative regulation of locomotion	FGF2;IL33;PTN;SPRED1;WNT5A	0.180065896010268
557	GO:0032570	0.0329985344199094	7.47868217054264	0.285787539526536	2	38	response to progesterone	PTN;TGFB2	0.180065896010268
558	GO:0032722	0.0329985344199094	7.47868217054264	0.285787539526536	2	38	positive regulation of chemokine production	IL33;WNT5A	0.180065896010268
559	GO:0045599	0.0329985344199094	7.47868217054264	0.285787539526536	2	38	negative regulation of fat cell differentiation	ID4;WNT5A	0.180065896010268
560	GO:0060038	0.0329985344199094	7.47868217054264	0.285787539526536	2	38	cardiac muscle cell proliferation	FGF2;TGFB2	0.180065896010268
561	GO:1902110	0.0329985344199094	7.47868217054264	0.285787539526536	2	38	positive regulation of mitochondrial membrane permeability involved in apoptotic process	ACAA2;BCL2L11	0.180065896010268
562	GO:0048738	0.0330385352784102	3.47467394601153	1.21083668062559	4	161	cardiac muscle tissue development	FGF2;PDGFRA;TGFB2;WNT5A	0.180065896010268
563	GO:0002009	0.0337292823289567	2.41630491672054	3.06845568754807	7	408	morphogenesis of an epithelium	FGF2;ID4;RBM15;RDH10;SOX4;TGFB2;WNT5A	0.180412581074415
564	GO:0042476	0.0337508327238416	4.46877828054299	0.706948124091958	3	94	odontogenesis	ASPN;BCL2L11;TGFB2	0.180412581074415
565	GO:0030155	0.0337846212390944	2.26517311608961	3.75284163746688	8	499	regulation of cell adhesion	HAS2;ITGAV;LGALS3;MARCH7;PAWR;PTN;TGFB2;WNT5A	0.180412581074415
566	GO:0010941	0.0338841276982801	1.80313408053134	9.04743184343219	15	1203	regulation of cell death	ACAA2;BCL2L11;CASP7;DYRK3;FGF2;ITGAV;LGALS3;MAP3K2;PAWR;PDGFRA;PTN;SOX4;STK17B;TGFB2;WNT5A	0.180412581074415
567	GO:0051480	0.034004754354546	2.92940994748224	1.79745320912742	5	239	regulation of cytosolic calcium ion concentration	FGF2;GSTO1;ITGAV;LPAR4;PDGFRA	0.180412581074415
568	GO:0042981	0.0345502262614333	1.83388084216813	8.27279719682078	14	1100	regulation of apoptotic process	ACAA2;BCL2L11;CASP7;DYRK3;ITGAV;LGALS3;MAP3K2;PAWR;PDGFRA;PTN;SOX4;STK17B;TGFB2;WNT5A	0.180412581074415
569	GO:0033762	0.0346152497444094	7.27592708988058	0.293308264250919	2	39	response to glucagon	GNB4;GNG12	0.180412581074415
570	GO:0048008	0.0346152497444094	7.27592708988058	0.293308264250919	2	39	platelet-derived growth factor receptor signaling pathway	PDGFRA;PIK3C2A	0.180412581074415
571	GO:0001838	0.0346670501635014	4.41982097186701	0.71446884881634	3	95	embryonic epithelial tube formation	SOX4;TGFB2;WNT5A	0.180412581074415
572	GO:0050680	0.0346670501635014	4.41982097186701	0.71446884881634	3	95	negative regulation of epithelial cell proliferation	PTN;TGFB2;WNT5A	0.180412581074415
573	GO:0032268	0.0347275553392283	1.65620759837178	14.056234509871	21	1869	regulation of cellular protein metabolic process	ABI1;ANOS1;ASPH;ASPN;BCL2L11;CASP7;CSNK1A1;FBXO5;FGF2;IL33;ITGAV;KBTBD8;MAP3K2;PDGFRA;PTN;RNF139;SOCS4;SOX4;SPRED1;TGFB2;WNT5A	0.180412581074415
574	GO:0055074	0.0351000046736446	2.59894155545329	2.43671481069994	6	324	calcium ion homeostasis	FGF2;GSTO1;ITGAV;LPAR4;PDGFRA;SLC30A1	0.180412581074415
575	GO:2001056	0.0355961167073362	4.3719165085389	0.721989573540723	3	96	positive regulation of cysteine-type endopeptidase activity	ASPH;BCL2L11;CASP7	0.180412581074415
576	GO:0048568	0.0360058519521617	2.58224085365854	2.45175626014871	6	326	embryonic organ development	MBD2;PDGFRA;RDH10;TGFB2;TRA2B;WNT5A	0.180412581074415
577	GO:0002697	0.0361324564006358	2.87916371367824	1.82753610802496	5	243	regulation of immune effector process	CFI;IL33;LGALS3;TGFB2;WNT5A	0.180412581074415
578	GO:0030850	0.0362622741946258	7.08384332925337	0.300828988975301	2	40	prostate gland development	ID4;WNT5A	0.180412581074415
579	GO:0060324	0.0362622741946258	7.08384332925337	0.300828988975301	2	40	face development	ASPH;WNT5A	0.180412581074415
580	GO:1902108	0.0362622741946258	7.08384332925337	0.300828988975301	2	40	regulation of mitochondrial membrane permeability involved in apoptotic process	ACAA2;BCL2L11	0.180412581074415
581	GO:1902686	0.0362622741946258	7.08384332925337	0.300828988975301	2	40	mitochondrial outer membrane permeabilization involved in programmed cell death	ACAA2;BCL2L11	0.180412581074415
582	GO:0030968	0.0365380009576665	4.32503128911139	0.729510298265105	3	97	endoplasmic reticulum unfolded protein response	BCL2L11;EDEM3;FKBP14	0.180412581074415
583	GO:0045807	0.0365380009576665	4.32503128911139	0.729510298265105	3	97	positive regulation of endocytosis	ITGAV;SCYL2;WNT5A	0.180412581074415
584	GO:0048565	0.0365380009576665	4.32503128911139	0.729510298265105	3	97	digestive tract development	PDGFRA;TGFB2;WNT5A	0.180412581074415
585	GO:0048519	0.036771583263207	1.5182419999577	27.623621912657	36	3673	negative regulation of biological process	ABI1;ACAA2;ANOS1;ASPH;ASPN;BTG3;CSNK1A1;DYRK3;FBXO5;FGF2;GSTO1;ID4;IL33;ITGAV;KLHL15;LGALS3;MARCH7;MBD2;OSGIN2;PAWR;PDGFRA;PTBP3;PTN;RBM15;RHOQ;RNF139;SALL3;SCYL2;SLC30A1;SOCS4;SOX4;SPRED1;SUZ12;TGFB2;TRA2B;WNT5A	0.180412581074415
586	GO:0071560	0.0370375738449159	3.34501898919077	1.25596102897188	4	167	cellular response to transforming growth factor beta stimulus	ASPN;FERMT2;TGFB2;WNT5A	0.180412581074415
587	GO:0002826	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	negative regulation of T-helper 1 type immune response	IL33	0.180412581074415
588	GO:0003097	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	renal water transport	HAS2	0.180412581074415
589	GO:0003278	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	apoptotic process involved in heart morphogenesis	TGFB2	0.180412581074415
590	GO:0007442	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	hindgut morphogenesis	WNT5A	0.180412581074415
591	GO:0009407	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	toxin catabolic process	GSTO1	0.180412581074415
592	GO:0010871	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	negative regulation of receptor biosynthetic process	ITGAV	0.180412581074415
593	GO:0010936	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	negative regulation of macrophage cytokine production	TGFB2	0.180412581074415
594	GO:0036302	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	atrioventricular canal development	HAS2	0.180412581074415
595	GO:0036514	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	dopaminergic neuron axon guidance	WNT5A	0.180412581074415
596	GO:0044531	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	modulation of programmed cell death in other organism	BCL2L11	0.180412581074415
597	GO:0044532	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	modulation of apoptotic process in other organism	BCL2L11	0.180412581074415
598	GO:0046826	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	negative regulation of protein export from nucleus	SOX4	0.180412581074415
599	GO:0048021	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	regulation of melanin biosynthetic process	WNT5A	0.180412581074415
600	GO:0048341	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	paraxial mesoderm formation	WNT5A	0.180412581074415
601	GO:0051024	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of immunoglobulin secretion	IL33	0.180412581074415
602	GO:0051890	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	regulation of cardioblast differentiation	TGFB2	0.180412581074415
603	GO:0052040	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	modulation by symbiont of host programmed cell death	BCL2L11	0.180412581074415
604	GO:0052150	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	modulation by symbiont of host apoptotic process	BCL2L11	0.180412581074415
605	GO:0052248	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	modulation of programmed cell death in other organism involved in symbiotic interaction	BCL2L11	0.180412581074415
606	GO:0052433	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	modulation by organism of apoptotic process in other organism involved in symbiotic interaction	BCL2L11	0.180412581074415
607	GO:0060029	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	convergent extension involved in organogenesis	WNT5A	0.180412581074415
608	GO:0060157	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	urinary bladder development	WNT5A	0.180412581074415
609	GO:0060316	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of ryanodine-sensitive calcium-release channel activity	GSTO1	0.180412581074415
610	GO:0060431	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	primary lung bud formation	RDH10	0.180412581074415
611	GO:0061438	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	renal system vasculature morphogenesis	PDGFRA	0.180412581074415
612	GO:0061439	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	kidney vasculature morphogenesis	PDGFRA	0.180412581074415
613	GO:0061626	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	pharyngeal arch artery morphogenesis	TGFB2	0.180412581074415
614	GO:0070487	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	monocyte aggregation	HAS2	0.180412581074415
615	GO:0090281	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	negative regulation of calcium ion import	SLC30A1	0.180412581074415
616	GO:0090500	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	endocardial cushion to mesenchymal transition	HAS2	0.180412581074415
617	GO:1900019	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	regulation of protein kinase C activity	WNT5A	0.180412581074415
618	GO:1900020	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of protein kinase C activity	WNT5A	0.180412581074415
619	GO:1901033	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of response to reactive oxygen species	PAWR	0.180412581074415
620	GO:1901628	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of postsynaptic membrane organization	PTN	0.180412581074415
621	GO:1902237	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway	BCL2L11	0.180412581074415
622	GO:1902474	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of protein localization to synapse	WNT5A	0.180412581074415
623	GO:1903911	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of receptor clustering	PTN	0.180412581074415
624	GO:1904938	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	planar cell polarity pathway involved in axon guidance	WNT5A	0.180412581074415
625	GO:1905007	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	TGFB2	0.180412581074415
626	GO:2000347	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of hepatocyte proliferation	PTN	0.180412581074415
627	GO:2000535	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	regulation of entry of bacterium into host cell	ITGAV	0.180412581074415
628	GO:2000774	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of cellular senescence	PAWR	0.180412581074415
629	GO:2001040	0.0370484862865841	33.3591954022989	0.0376036236219127	1	5	positive regulation of cellular response to drug	PAWR	0.180412581074415
630	GO:0043067	0.0371452440743183	1.81359481632955	8.35552516878899	14	1111	regulation of programmed cell death	ACAA2;BCL2L11;CASP7;DYRK3;ITGAV;LGALS3;MAP3K2;PAWR;PDGFRA;PTN;SOX4;STK17B;TGFB2;WNT5A	0.180596639047043
631	GO:0051250	0.0374926697414949	4.27913312693498	0.737031022989488	3	98	negative regulation of lymphocyte activation	LGALS3;MARCH7;PAWR	0.181996905575593
632	GO:0002066	0.0379390717610265	6.90161001788909	0.308349713699684	2	41	columnar/cuboidal epithelial cell development	SLC4A7;WNT5A	0.183003742998463
633	GO:0035904	0.0379390717610265	6.90161001788909	0.308349713699684	2	41	aorta development	SOX4;TGFB2	0.183003742998463
634	GO:0048546	0.0379390717610265	6.90161001788909	0.308349713699684	2	41	digestive tract morphogenesis	PDGFRA;WNT5A	0.183003742998463
635	GO:0060042	0.0379390717610265	6.90161001788909	0.308349713699684	2	41	retina morphogenesis in camera-type eye	PTN;TSPAN12	0.183003742998463
636	GO:0031589	0.038341043262694	2.83057851239669	1.85761900692249	5	247	cell-substrate adhesion	BCL2L11;FERMT2;HAS2;ITGAV;PTN	0.184651911184955
637	GO:0010646	0.0387473492363184	1.56290975611316	19.4786770361508	27	2590	regulation of cell communication	ACAA2;ASPN;BCL2L11;CSNK1A1;DYRK3;FGF2;GSTO1;IL33;ITGAV;LGALS3;LPAR4;MAP3K2;MBD2;NAMPT;OSGIN2;PAWR;PDGFRA;PTN;RHOQ;SALL3;SCYL2;SLC30A1;SOCS4;SOX4;SPRED1;TGFB2;WNT5A	0.186315746798812
638	GO:0050714	0.0391376061444727	3.28370625358577	1.27852320314503	4	170	positive regulation of protein secretion	IL33;SOX4;TGFB2;WNT5A	0.187603267011768
639	GO:0071559	0.0391376061444727	3.28370625358577	1.27852320314503	4	170	response to transforming growth factor beta	ASPN;FERMT2;TGFB2;WNT5A	0.187603267011768
640	GO:0010517	0.0396451126194623	6.72848837209302	0.315870438424066	2	42	regulation of phospholipase activity	FGF2;PDGFRA	0.187686213220113
641	GO:0010596	0.0396451126194623	6.72848837209302	0.315870438424066	2	42	negative regulation of endothelial cell migration	FGF2;SPRED1	0.187686213220113
642	GO:0035794	0.0396451126194623	6.72848837209302	0.315870438424066	2	42	positive regulation of mitochondrial membrane permeability	ACAA2;BCL2L11	0.187686213220113
643	GO:0042130	0.0396451126194623	6.72848837209302	0.315870438424066	2	42	negative regulation of T cell proliferation	MARCH7;PAWR	0.187686213220113
644	GO:0043536	0.0396451126194623	6.72848837209302	0.315870438424066	2	42	positive regulation of blood vessel endothelial cell migration	FGF2;PIK3C2A	0.187686213220113
645	GO:0043550	0.0396451126194623	6.72848837209302	0.315870438424066	2	42	regulation of lipid kinase activity	FGF2;PDGFRA	0.187686213220113
646	GO:0048146	0.0396451126194623	6.72848837209302	0.315870438424066	2	42	positive regulation of fibroblast proliferation	PDGFRA;WNT5A	0.187686213220113
647	GO:1905710	0.0396451126194623	6.72848837209302	0.315870438424066	2	42	positive regulation of membrane permeability	ACAA2;BCL2L11	0.187686213220113
648	GO:0072503	0.039780092997881	2.5174747174301	2.51192205794377	6	334	cellular divalent inorganic cation homeostasis	FGF2;GSTO1;ITGAV;LPAR4;PDGFRA;SLC30A1	0.188034606253873
649	GO:0042176	0.040050908615154	2.79518072289157	1.88018118109563	5	250	regulation of protein catabolic process	CSNK1A1;IL33;RNF139;SOCS4;WNT5A	0.188773142399049
650	GO:0007154	0.0400595960037158	1.48922670191672	34.4599606871208	43	4582	cell communication	ABI1;ACAA2;ANOS1;ASPN;BCL2L11;CSNK1A1;DYRK3;EDEM3;FERMT2;FGF2;FIBIN;FKBP14;GNB4;GNG12;GSTO1;IL33;ITGAV;LGALS3;LPAR4;MAP3K2;MBD2;NAMPT;OSGIN2;PAWR;PDGFRA;PIK3C2A;PTN;PTPRZ1;RAB39A;RBM15;RHOQ;RND3;SALL3;SCYL2;SLC30A1;SOCS4;SOX4;SPRED1;SS18;STK17B;TGFB2;TSPAN12;WNT5A	0.188773142399049
651	GO:0042770	0.0404330257390251	4.14705882352941	0.759593197162636	3	101	signal transduction in response to DNA damage	DYRK3;SOX4;SPRED1	0.190240181011726
652	GO:0006909	0.0405749351910918	3.24404761904762	1.2935646525938	4	172	phagocytosis	ABI1;CSNK1A1;ITGAV;RAB39A	0.190615071304163
653	GO:0030097	0.041148398406696	2.06924426619877	4.62524570549526	9	615	hemopoiesis	ABI1;DYRK3;LGALS3;PTBP3;PTPRZ1;RBM15;SOX4;TGFB2;WNT5A	0.191649202196374
654	GO:0000380	0.04137987307019	6.56381168462847	0.323391163148449	2	43	alternative mRNA splicing, via spliceosome	TRA2B;WTAP	0.191649202196374
655	GO:0002718	0.04137987307019	6.56381168462847	0.323391163148449	2	43	regulation of cytokine production involved in immune response	TGFB2;WNT5A	0.191649202196374
656	GO:0046426	0.04137987307019	6.56381168462847	0.323391163148449	2	43	negative regulation of JAK-STAT cascade	ASPN;SOCS4	0.191649202196374
657	GO:0048645	0.04137987307019	6.56381168462847	0.323391163148449	2	43	animal organ formation	RDH10;WNT5A	0.191649202196374
658	GO:0060563	0.04137987307019	6.56381168462847	0.323391163148449	2	43	neuroepithelial cell differentiation	SLC4A7;SOX4	0.191649202196374
659	GO:1904893	0.04137987307019	6.56381168462847	0.323391163148449	2	43	negative regulation of STAT cascade	ASPN;SOCS4	0.191649202196374
660	GO:0046165	0.0414384667568499	4.1048128342246	0.767113921887018	3	102	alcohol biosynthetic process	ACAA2;FGF2;IPMK	0.191649202196374
661	GO:0006397	0.0417586256186735	2.48626212165736	2.5420049568413	6	338	mRNA processing	AQR;LGALS3;PTBP3;RBM15;TRA2B;WTAP	0.191649202196374
662	GO:0048870	0.0419579896344571	1.77949723917466	8.49841893855226	14	1130	cell motility	FGF2;HAS2;IL33;ITGAV;LGALS3;PDGFRA;PIK3C2A;PTN;RHOQ;RND3;SLC7A11;SPRED1;TGFB2;WNT5A	0.191649202196374
663	GO:0051674	0.0419579896344571	1.77949723917466	8.49841893855226	14	1130	localization of cell	FGF2;HAS2;IL33;ITGAV;LGALS3;PDGFRA;PIK3C2A;PTN;RHOQ;RND3;SLC7A11;SPRED1;TGFB2;WNT5A	0.191649202196374
664	GO:0006511	0.0419670605319705	2.29741063311926	3.21887018203572	7	428	ubiquitin-dependent protein catabolic process	CSNK1A1;EDEM3;IL33;KLHL15;RNF139;SOCS4;USP38	0.191649202196374
665	GO:0030100	0.0420421308503327	3.20532212885154	1.30860610204256	4	174	regulation of endocytosis	ITGAV;LGALS3;SCYL2;WNT5A	0.191649202196374
666	GO:0072175	0.0424565011422985	4.06341176470588	0.774634646611401	3	103	epithelial tube formation	SOX4;TGFB2;WNT5A	0.191649202196374
667	GO:0007265	0.043282904596967	2.46334182744813	2.56456713101444	6	341	Ras protein signal transduction	FGF2;LPAR4;RAB39A;RHOQ;RND3;TGFB2	0.191649202196374
668	GO:0002262	0.0434870858603927	4.02283051834595	0.782155371335783	3	104	myeloid cell homeostasis	BCL2L11;DYRK3;PTBP3	0.191649202196374
669	GO:0007062	0.0434870858603927	4.02283051834595	0.782155371335783	3	104	sister chromatid cohesion	CENPN;MCMBP;NAA50	0.191649202196374
670	GO:0010498	0.0437987247807006	2.45579268292683	2.57208785573883	6	342	proteasomal protein catabolic process	CSNK1A1;EDEM3;IL33;KLHL15;RNF139;SOCS4	0.191649202196374
671	GO:0000183	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	chromatin silencing at rDNA	MBD2	0.191649202196374
672	GO:0002638	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	negative regulation of immunoglobulin production	IL33	0.191649202196374
673	GO:0003402	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	planar cell polarity pathway involved in axis elongation	WNT5A	0.191649202196374
674	GO:0007144	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	female meiosis I	FBXO5	0.191649202196374
675	GO:0007185	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	transmembrane receptor protein tyrosine phosphatase signaling pathway	PTN	0.191649202196374
676	GO:0010764	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	negative regulation of fibroblast migration	FGF2	0.191649202196374
677	GO:0017185	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	peptidyl-lysine hydroxylation	PLOD2	0.191649202196374
678	GO:0019388	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	galactose catabolic process	PGM2	0.191649202196374
679	GO:0032905	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	transforming growth factor beta1 production	LUM	0.191649202196374
680	GO:0032908	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	regulation of transforming growth factor beta1 production	LUM	0.191649202196374
681	GO:0033278	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	cell proliferation in midbrain	WNT5A	0.191649202196374
682	GO:0034085	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	establishment of sister chromatid cohesion	NAA50	0.191649202196374
683	GO:0038030	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	non-canonical Wnt signaling pathway via MAPK cascade	WNT5A	0.191649202196374
684	GO:0038031	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	non-canonical Wnt signaling pathway via JNK cascade	WNT5A	0.191649202196374
685	GO:0045837	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	negative regulation of membrane potential	PTN	0.191649202196374
686	GO:0046929	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	negative regulation of neurotransmitter secretion	SLC30A1	0.191649202196374
687	GO:0048563	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	post-embryonic animal organ morphogenesis	BCL2L11	0.191649202196374
688	GO:0051964	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	negative regulation of synapse assembly	WNT5A	0.191649202196374
689	GO:0060315	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	negative regulation of ryanodine-sensitive calcium-release channel activity	GSTO1	0.191649202196374
690	GO:0060449	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	bud elongation involved in lung branching	RDH10	0.191649202196374
691	GO:0060907	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	positive regulation of macrophage cytokine production	WNT5A	0.191649202196374
692	GO:0061525	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	hindgut development	WNT5A	0.191649202196374
693	GO:0070444	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	oligodendrocyte progenitor proliferation	PTPRZ1	0.191649202196374
694	GO:0070445	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	regulation of oligodendrocyte progenitor proliferation	PTPRZ1	0.191649202196374
695	GO:0071578	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	zinc ion import across plasma membrane	SLC30A1	0.191649202196374
696	GO:0090343	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	positive regulation of cell aging	PAWR	0.191649202196374
697	GO:0150011	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	regulation of neuron projection arborization	WNT5A	0.191649202196374
698	GO:0150012	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	positive regulation of neuron projection arborization	WNT5A	0.191649202196374
699	GO:1900376	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	regulation of secondary metabolite biosynthetic process	WNT5A	0.191649202196374
700	GO:1902473	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	regulation of protein localization to synapse	WNT5A	0.191649202196374
701	GO:1903896	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	positive regulation of IRE1-mediated unfolded protein response	BCL2L11	0.191649202196374
702	GO:1904396	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	regulation of neuromuscular junction development	PTN	0.191649202196374
703	GO:1905005	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	regulation of epithelial to mesenchymal transition involved in endocardial cushion formation	TGFB2	0.191649202196374
704	GO:2000049	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	positive regulation of cell-cell adhesion mediated by cadherin	WNT5A	0.191649202196374
705	GO:2000587	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	negative regulation of platelet-derived growth factor receptor-beta signaling pathway	PDGFRA	0.191649202196374
706	GO:2000739	0.0442936755142492	26.6850574712644	0.0451243483462952	1	6	regulation of mesenchymal stem cell differentiation	PDGFRA	0.191649202196374
707	GO:0048863	0.0442989341021981	3.14891274428847	1.33116827621571	4	177	stem cell differentiation	KBTBD8;PDGFRA;RDH10;TGFB2	0.191649202196374
708	GO:0061448	0.0442989341021981	3.14891274428847	1.33116827621571	4	177	connective tissue development	FGF2;ID4;LUM;WNT5A	0.191649202196374
709	GO:0021872	0.0449334882095784	6.25743645213629	0.338432612597214	2	45	forebrain generation of neurons	SALL3;WNT5A	0.193031240372985
710	GO:0032755	0.0449334882095784	6.25743645213629	0.338432612597214	2	45	positive regulation of interleukin-6 production	IL33;WNT5A	0.193031240372985
711	GO:0046173	0.0449334882095784	6.25743645213629	0.338432612597214	2	45	polyol biosynthetic process	FGF2;IPMK	0.193031240372985
712	GO:0060193	0.0449334882095784	6.25743645213629	0.338432612597214	2	45	positive regulation of lipase activity	FGF2;PDGFRA	0.193031240372985
713	GO:0070527	0.0449334882095784	6.25743645213629	0.338432612597214	2	45	platelet aggregation	PDGFRA;SLC7A11	0.193031240372985
714	GO:0019941	0.0451360165204848	2.25842275297104	3.2715152551064	7	435	modification-dependent protein catabolic process	CSNK1A1;EDEM3;IL33;KLHL15;RNF139;SOCS4;USP38	0.193629717930315
715	GO:0014065	0.0455857266050025	3.94403198172473	0.797196820784548	3	106	phosphatidylinositol 3-kinase signaling	PDGFRA;PIK3C2A;TGFB2	0.195012682389836
716	GO:0055123	0.0455857266050025	3.94403198172473	0.797196820784548	3	106	digestive system development	PDGFRA;TGFB2;WNT5A	0.195012682389836
717	GO:0042129	0.0466536891160473	3.90576923076923	0.804717545508931	3	107	regulation of T cell proliferation	LGALS3;MARCH7;PAWR	0.198062669779505
718	GO:0050777	0.0466536891160473	3.90576923076923	0.804717545508931	3	107	negative regulation of immune response	IL33;LGALS3;TGFB2	0.198062669779505
719	GO:0061351	0.0466536891160473	3.90576923076923	0.804717545508931	3	107	neural precursor cell proliferation	ID4;PTPRZ1;WNT5A	0.198062669779505
720	GO:0030111	0.0467155616600239	2.67248682228916	1.96290915306384	5	261	regulation of Wnt signaling pathway	CSNK1A1;MBD2;SCYL2;SOX4;WNT5A	0.198062669779505
721	GO:0019748	0.0467513255796873	6.1146934460888	0.345953337321596	2	46	secondary metabolic process	GSTO1;WNT5A	0.198062669779505
722	GO:0050854	0.0467513255796873	6.1146934460888	0.345953337321596	2	46	regulation of antigen receptor-mediated signaling pathway	LGALS3;PAWR	0.198062669779505
723	GO:1904063	0.0467513255796873	6.1146934460888	0.345953337321596	2	46	negative regulation of cation transmembrane transport	GSTO1;SLC30A1	0.198062669779505
724	GO:0097190	0.0470147687944343	2.23671124828532	3.30159815400393	7	439	apoptotic signaling pathway	ACAA2;BCL2L11;IL33;ITGAV;LGALS3;PAWR;TGFB2	0.198903642012917
